Document:

EXHIBIT 10.2

                     FOUNDERS' VOTING AND SUPPORT AGREEMENT
                     --------------------------------------

                                  by and among

              Alternative Asset Management Acquisition Corporation,

     Halcyon Employees LP, solely in its capacity as Halcyon Representative

                                       and

   Hanover Overseas Limited, STC Investment Holdings LLC, Solar Capital, LLC,
    Jakal Investments, LLC, Mark D. Klein, David Hawkins, Steven A. Shenfeld,
                    Bradford R. Peck and Frederick G. Kraegel

                                  March o, 2008

<PAGE>

                                TABLE OF CONTENTS

ARTICLE I DEFINITIONS........................................................  1
   Section 1.1     Definitions...............................................  1
   Section 1.2     Gender....................................................  4

ARTICLE II COVENANTS TO SUPPORT THE ACQUISITION..............................  4
   Section 2.1     Voting of Founders' Securities............................  4
   Section 2.2     No Restraint on Officer or Director Action................  4
   Section 2.3     10b5-1 Agreements.........................................  5

ARTICLE III TRANSFER RESTRICTIONS............................................  5
   Section 3.1     Transfer Restrictions.....................................  5

ARTICLE IV ASSIGNMENT; THIRD PARTY BENEFICIARIES.............................  5
   Section 4.1     Assignment................................................  5
   Section 4.2     Third Party Beneficiary...................................  5

ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE FOUNDERS.....................  6
   Section 5.1     Good Standing.............................................  6
   Section 5.2     Due Authorization; Binding Agreement......................  6
   Section 5.3     No Conflicts..............................................  6
   Section 5.4     Ownership of the Founders' Securities.....................  7
   Section 5.5     Founders' Prior Agreements................................  7
   Section 5.6     Litigation................................................  7
   Section 5.7     Accuracy of Representations; Reliance by
                     Halcyon Representative..................................  7

ARTICLE VI FURTHER ASSURANCES................................................  7
   Section 6.1     Shareholders Agreement....................................  7
   Section 6.2     Further Assurances........................................  7

ARTICLE VII ADJUSTMENTS AND OTHER AGREEMENTS.................................  8
   Section 7.1     Surrender and Cancellation of Founders' Securities........  8
   Section 7.2     Termination Fee Securities................................  8
   Section 7.3     Adjustments to Prevent Dilution...........................  9

ARTICLE VIII TERMINATION.....................................................  9
   Section 8.1     Termination...............................................  9
   Section 8.2     Survival..................................................  9

ARTICLE IX GENERAL PROVISIONS................................................  9
   Section 9.1     Amendments................................................  9
   Section 9.2     Notices...................................................  9
   Section 9.3     Interpretation............................................ 10
   Section 9.4     Remedies Cumulative....................................... 10
   Section 9.5     Waivers................................................... 10
   Section 9.6     Severability.............................................. 10
   Section 9.8     Governing Law............................................. 10
   Section 9.9     Entire Agreement.......................................... 10
   Section 9.10    Fees and Expenses......................................... 11

<PAGE>

   Section 9.11    Legal Counsel............................................. 11
   Section 9.12    Specific Performance; Enforcement......................... 11
   Section 9.13    Consent to Jurisdiction................................... 11
   Section 9.14    Counterparts:  Facsimile.................................. 11

   Exhibit A       Beneficial and Record Ownership of Founders' Securities
   Exhibit B       Cancellation Shares and Termination Fee Securities

<PAGE>

                     FOUNDERS' VOTING AND SUPPORT AGREEMENT
                     --------------------------------------

      AGREEMENT, dated as of March 12th, 2008 (this "Agreement"), by and among
Alternative Asset Management Acquisition Corporation ("AAMAC"), Halcyon
Employees LP, solely in its capacity as the Halcyon Representative, Hanover
Overseas Limited, STC Investment Holdings LLC, Solar Capital, LLC, Jakal
Investments, LLC, Mark D. Klein, David Hawkins, Steven A. Shenfeld, Bradford R.
Peck and Frederick G. Kraegel (each a "Founder" and collectively, the
"Founders") (capitalized terms used but not defined herein have the meanings set
forth in Article I).

      WHEREAS, AAMAC, Halcyon Management Group LLC ("Halcyon"), Halcyon Partner
Vehicle, Halcyon Asset Management LLC, Halcyon Offshore Asset Management LLC,
Halcyon Structured Asset Management LP, Halcyon Asset-Backed Advisors LP,
Halcyon Loan Investors LP, and Halcyon Real Estate Investors LP entered into the
Purchase Agreement on the date hereof whereby AAMAC will acquire certain equity
interests in Halcyon (the "Purchase Agreement");

      WHEREAS, as of the date hereof each Founder owns, beneficially and of
record, the number of shares of AAMAC Common Stock entitled to vote (the
"Founders' Common Shares") and warrants exercisable for AAMAC Common Stock (the
"Sponsors' Warrants"), in each case in such amounts as set forth opposite each
Founder's name on Exhibit A hereto (the Founders' Common Shares and Sponsors'
Warrants, together, the "Founders' Securities");

      WHEREAS, Halcyon Representative and the Founders desire to enter into this
Agreement to provide for, among other things, (i) the obligation of the
Founders, subject to the terms of this Agreement and the Letter Agreements, to
vote their Founders' Voting Shares as set forth herein; (ii) certain
restrictions on the sale or other Transfer of the record ownership or the
Beneficial Ownership, or both, of the Founders' Securities until the termination
of this Agreement; and (iii) the cancellation of a portion of the Founders'
Common Shares at the Closing Date; and

      WHEREAS, as a condition to the willingness of Halcyon Parties to enter
into the Purchase Agreement, the Halcyon Parties have required that the Founders
enter into this Agreement.

      NOW, THEREFORE, the parties agree as follows:

                                   ARTICLE I

                                  DEFINITIONS

      Section 1.1 Definitions. As used in this Agreement, the following terms
have the following meanings:

      "10b5-1 Agreements" means the three agreements dated July 24, 2007 which
Citigroup Global Markets Inc. and AAMAC entered into with each of Hanover
Overseas Limited, STC

                                       1
<PAGE>

Investment Holdings LLC and Solar Capital, LLC, a form of which is filed as
Exhibit 10.10 to Form S-1 (file number 333-141593) filed with the SEC by AAMAC.

      "AAMAC" has the meaning set forth in the introduction to this Agreement.

      "AAMAC Common Stock" means the common stock, $0.0001 par value per share,
of AAMAC.

      "Acquisition" means the acquisition whereby, pursuant to the Purchase
Agreement and the transactions contemplated thereby, as from time to time
amended, AAMAC will acquire all of the Class A Units of Halcyon.

      "Action" means any legal, administrative, governmental or regulatory
proceeding or other action, suit, proceeding, claim, arbitration, mediation,
alternative dispute resolution procedure, inquiry or investigation by or before
any arbitrator, mediator, court or other Governmental Entity.

      "Agreement" has the meaning set forth in the introduction to this
Agreement.

      "Beneficial Owner" of a security is a Person who directly or indirectly,
through any contract, arrangement, understanding, relationship or otherwise has
or shares: (i) voting power, which includes the power to vote, or to direct the
voting of, such security and/or (ii) investment power, which includes the power
to dispose, or to direct the disposition of, such security. The terms
"Beneficially Own" and "Beneficial Ownership" shall have correlative meanings.

      "Business Day" means a day on which banks and stock exchanges are open for
business in New York (excluding Saturdays, Sundays and public holidays).

      "Cancellation Shares" has the meaning set forth in Section 7.1 of this
Agreement.

      "Closing Date" has the meaning set forth in the Purchase Agreement.

      "Control" means the possession, direct or indirect, of the power to direct
or cause the direction of the management and policies of a Person, whether
through ownership of voting securities, by contract or otherwise.

      "Escrow Agreement" means that Escrow Agreement dated August 1, 2007
between AAMAC, the Founders, and Continental Stock Transfer & Trust Company.

      "Exchange Act" means the Securities Exchange Act of 1934, as amended.

      "Founder" has the meaning set forth in the introduction to this Agreement.

      "Founders' Common Shares" has the meaning set forth in the recitals to
this Agreement.

      "Founders' Securities" has the meaning set forth in the recitals to this
Agreement.

      "Founders' Voting Shares" has the meaning set forth in Section 2.1(a)(i)
of this Agreement.

                                       2
<PAGE>

      "Governmental Entity" means any court, administrative agency, regulatory
body, commission or other governmental authority, board, bureau or
instrumentality, domestic or foreign and any subdivision thereof.

      "Halcyon" has the meaning set forth in the recitals to this Agreement.

      "Halcyon Parties" has the meaning set forth in the Purchase Agreement.

      "Halcyon Partner Vehicle" has the meaning set forth in the Purchase
Agreement.

      "Halcyon Representative" has the meaning set forth in the Purchase
Agreement.

      "Letter Agreement" means each of the letter agreements dated August 1,
2007 between AAMAC and each of the Founders, respectively.

      "Permitted Transferee" has the meaning set forth in the Warrant Agreement.

      "Person" means any individual, corporation, firm, partnership, joint
venture, limited liability company, estate, trust, business association,
organization, Governmental Entity or other entity.

      "Purchase Agreement" has the meaning set forth in the recitals to this
Agreement.

      "Registration Rights Agreement" means that Registration Rights Agreement
dated August 1, 2007 between AAMAC and the Founders.

      "SEC" means the Securities and Exchange Commission.

      "Sponsors' Warrants" has the meaning set forth in the recitals to this
Agreement.

      "Termination Fee Securities" has the meaning set forth in Section 7.2(a)
of this Agreement.

      "Transfer" means to (a) directly or indirectly offer, sell, contract to
sell, grant any option or warrant for the sale of, assign, transfer,
hypothecate, pledge or otherwise encumber or dispose of any Founders Securities
except for security arrangements currently in place as of the date hereof with
respect to indebtedness of Solar Capital, LLC (b) enter into any swap or other
transaction which is designed to, or might reasonably be expected to, result in
the disposition, whether by actual disposition or effective economic disposition
due to cash settlement or otherwise, of Founders' Securities (including the
filing or participation in the filing of a registration statement with the SEC)
or (c) establish or increase a put equivalent position or liquidate or decrease
a call equivalent position relating to Founders' Securities within the meaning
of Section 16 of the Exchange Act and the rules and regulations promulgated
thereunder.

      "Voting Event" has the meaning set forth in Section 2.1(a) of this
Agreement.

      "Voting Matters" has the meaning set forth in the Purchase Agreement.

                                       3
<PAGE>

      "Warrant Agreement" means the Warrant Agreement dated as of August 1, 2007
between AAMAC and Continental Stock Transfer & Trust Company.

      Section 1.2 Gender. For the purposes of this Agreement, the words "he,"
"his" or "himself" shall be interpreted to include the masculine, feminine and
corporate, other entity or trust form.

                                   ARTICLE II

                      COVENANTS TO SUPPORT THE ACQUISITION

      Until the termination of this Article in accordance with Section 8.1, the
Founders agree as follows:

      Section 2.1 Voting of Founders' Securities.

      (a) The Founders agree that, from and after the date hereof and until this
Agreement is terminated pursuant to Article VIII, below, at any meeting of the
stockholders of AAMAC, however called, or in connection with any written consent
of the stockholders of AAMAC, in each case relating to any proposed action by
the stockholders of AAMAC with respect to the matters set forth in Section
2.1(a)(iii) below (each, a "Voting Event"):

      (i) each Founder shall appear at or participate in, as applicable, each
      such Voting Event or otherwise cause the Founders' Common Shares, and any
      voting securities of AAMAC acquired by any Founder after the date hereof
      and prior to the record date of such Voting Event (including voting
      securities purchased pursuant to the 10b5-1 Agreements) (such shares,
      together, the "Founders' Voting Shares"), to be counted as present thereat
      for purposes of calculating a quorum; and

      (ii) each Founder shall vote all of such Founders' Common Shares as
      required by Section 1 of the Letter Agreement executed by such Founder;
      and

      (iii) subject to Section 2.1(a)(ii), each Founder shall vote (or cause to
      be voted), in person or by proxy, all Founders' Voting Shares: (a) in
      favor of the Voting Matters, including the Acquisition; (b) in favor of
      any matter necessary or advisable to effect or further the transactions
      contemplated by the Voting Matters; (c) against any action or agreement
      submitted for adoption of the stockholders of AAMAC that would result in a
      material breach of any covenant, representation or warranty or any other
      obligation or agreement of AAMAC contained in the Purchase Agreement or of
      the Founders' contained in this Agreement; and (d) against any action or
      agreement that would reasonably be expected to adversely affect or delay
      the Acquisition or other Voting Matters in any respect.

      Section 2.2 No Restraint on Officer or Director Action. The agreements set
forth herein shall in no way restrict any such director or officer in the
exercise of his fiduciary duties as a director or officer of AAMAC. Each Founder
has executed this Agreement solely in his capacity as the Beneficial Owner of
Founders' Securities and no action taken by any such

                                       4
<PAGE>

director or officer solely in such Person's capacity as a director or officer of
AAMAC shall be deemed to constitute a breach of any provision of this Agreement.

      Section 2.3 10b5-1 Agreements. Hanover Overseas Limited, STC Investment
Holdings LLC and Solar Capital, LLC shall maintain the 10b5-1 Agreements in full
force and effect, and shall not alter, amend, grant any release under or
relinquish any rights relating to the 10b5-1 Agreements.

                                  ARTICLE III

                              TRANSFER RESTRICTIONS

      Section 3.1 Transfer Restrictions.

      (a) No Founder may directly or indirectly Transfer, or publicly announce
an intention to effect any Transfer, prior to the Closing Date except to a
Permitted Transferee that executes a joinder to this Agreement agreeing to be
bound by the terms and conditions hereof.

      (b) From and after the date hereof and until the termination of this
Article pursuant to Article VIII, each Founder agrees not to, with the exception
of the obligations undertaken pursuant to this Agreement, obligations existing
pursuant to the Letter Agreements and any Transfers permitted pursuant to
Section 3.1(a) above, (i) deposit any of his Founders' Securities into a voting
trust, enter into any voting arrangement or understanding, or otherwise
Transfer, whether by proxy, voting agreement or otherwise, the right to vote his
Founders Securities or (ii) take any action that would make any of his
representations or warranties contained herein untrue or incorrect or have the
effect of preventing, disabling or impeding such Founder from performing such
Founder's obligations under this Agreement.

                                   ARTICLE IV

                      ASSIGNMENT; THIRD PARTY BENEFICIARIES

      Section 4.1 Assignment. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned by any of the parties
hereto (whether by operation of law or otherwise) without the prior written
consent of the other parties except by the Founders to any Permitted Transferee
pursuant to the terms of Section 3.1(a) hereof. This Agreement will be binding
upon, inure to the benefit of and be enforceable by the parties and their
respective successors and assigns.

      Section 4.2 Third Party Beneficiary. Except for the rights granted to
Halcyon Partner Vehicle pursuant to Section 7.2 of this Agreement, this
Agreement (including the documents and instruments referred to herein) is not
intended to confer upon any Person other than the parties hereto any rights or
remedies hereunder.

                                       5
<PAGE>

                                   ARTICLE V

                 REPRESENTATIONS AND WARRANTIES OF THE FOUNDERS

      Each of the Founders hereby represents and warrants to Halcyon
Representative, severally and not jointly, as of the date hereof, as follows:

      Section 5.1 Good Standing. In the case of Founders who are not natural
persons, such Founder is duly organized, validly existing and in good standing
under the laws of the jurisdiction where it is organized.

      Section 5.2 Due Authorization; Binding Agreement. Each Founder has all
requisite legal capacity or other power and authority to enter into this
Agreement and to perform its obligations hereunder. In the case of Founders who
are not natural persons, the execution and delivery of this Agreement and the
performance by such Founder of its obligations hereunder have been duly
authorized by all necessary action. This Agreement has been duly executed and
delivered by each Founder and, assuming due authorization and valid execution
and delivery by the other parties hereto, constitutes a valid and binding
agreement of the Founder enforceable against the Founder in accordance with its
terms, except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, fraudulent conveyance, moratorium and other similar laws
relating to or affecting creditors generally or general equity principles
(regardless of whether such enforceability is considered in a proceeding in
equity or at law).

      Section 5.3 No Conflicts.

      (a) The execution and delivery by each Founder of this Agreement does not,
and the performance by each Founder of its obligations hereunder will not,
conflict with, or result in any breach or violation of, or constitute a default
(with or without notice or lapse of time, or both) under, or give rise to a
right of or result by its terms in the termination, amendment, cancellation or
acceleration of any obligation or the loss of a material benefit under or the
creation of a lien, charge, "put" or "call" right or other encumbrance on, or
the loss of, any of the Founder's Securities Beneficially Owned by such Founder
under or pursuant to (i), in the case of a Founder which is not a natural
person, any provision of the partnership agreement, operating agreement or other
organizational documents of such Founder or (ii) (A) any material contract to
which such Founder is a party or by which any of such Founder's properties or
assets is bound other than the Escrow Agreement or (B) any material permit,
concession, franchise, license, judgment, order, decree, statute, law,
ordinance, rule or regulation applicable to such Founder or such Founder's
properties or assets.

      (b) Except for filings with the SEC under the Exchange Act and the
approval of Continental Stock Transfer & Trust Company and Citigroup Global
Markets Inc to amend the Escrow Agreement, no consent, approval, order or
authorization of, or registration, declaration or filing with, any Governmental
Entity or any other Person is required by or with respect to such Founder in
connection with the execution of this Agreement by such Founder and the
consummation by such Founder of the transactions contemplated hereby.

                                       6
<PAGE>

      Section 5.4 Ownership of the Founders' Securities. Such Founder is the
owner of record of the Founders' Securities set forth opposite such Founder's
name on Exhibit A. No Founder Beneficially Owns any shares of capital stock of
AAMAC or any options or other securities convertible into or exchangeable for
shares of capital stock of AAMAC, other than the Founders' Securities. Each
Founder has the sole right and power to vote and dispose of the Founders'
Securities Beneficially Owned by such Founder, and none of such Founders'
Securities is subject to any voting trust or other agreement, arrangement or
restriction with respect to the voting or Transfer of any of the Founders'
Securities, except for (i) this Agreement, (ii) the Letter Agreement executed by
such Founder, (iii) the Escrow Agreement (iv) and the Registration Rights
Agreement, true and complete copies of which have been provided previously to
the Halcyon Representative.

      Section 5.5 Founders' Prior Agreements. Other than as a result of this
Agreement, each Founder and to such Founder's knowledge the parties thereto, is
not in breach or default, nor is there any fact, circumstance or event that,
with or without notice or lapse of time, or both, would result in any breach or
default under the terms of any 10b5-1 Agreement, the Warrant Agreement or the
Escrow Agreement. Each of the 10b5-1 Agreements, the Warrant Agreement and the
Escrow Agreement is a valid and binding obligation of the Founder which is a
party thereto and to the knowledge of each Founder, of each other party thereto,
and is in full force and effect.

      Section 5.6 Litigation. With respect to each Founder, there is no Action
pending to which such Founder is a party or, to the knowledge of such Founder,
threatened against or by such Founder that restricts in any material respect or
prohibits (or, if successful, would reasonably be expected to restrict or
prohibit) the exercise by any party of its rights under this Agreement or the
performance by any party of its obligations under this Agreement.

      Section 5.7 Accuracy of Representations; Reliance by Halcyon
Representative. The representations and warranties contained in this Agreement
are accurate in all respects as of the date of this Agreement. Each Founder
understands and acknowledges that the Halcyon Representative is entering into
the Purchase Agreement in reliance upon the Founders' execution and delivery of
this Agreement.

                                   ARTICLE VI

                               FURTHER ASSURANCES

      Section 6.1 Shareholders Agreement. The Founders agree that on or prior to
the Closing Date, the Founders shall enter into the Shareholders Agreement, as
contemplated by the Purchase Agreement and on the terms described therein.

      Section 6.2 Further Assurances. AAMAC and the Founders shall, from time to
time, execute and deliver, or cause to be executed and delivered, such
additional or further consents, documents and other instruments as Halcyon
Representative may reasonably request for the purpose of effectively carrying
out the transactions or arrangements contemplated by this Agreement, including
effecting any amendment, if necessary, to the Escrow Agreement substantially in
the form attached hereto as Exhibit C.

                                       7
<PAGE>

                                  ARTICLE VII

                        ADJUSTMENTS AND OTHER AGREEMENTS

      Section 7.1 Surrender and Cancellation of Founders' Securities. On the
Closing Date, the Founders shall deliver to AAMAC or its transfer agent, as may
be directed by AAMAC, 2,580,000 Founders' Common Shares in the proportion per
Founder set out in the column named "Cancellation Shares" on Exhibit B hereto
(the "Cancellation Shares"). Regardless of whether such delivery is completed,
on the Closing Date AAMAC or its transfer agent shall cancel such Cancellation
Shares in accordance with Section 2.2(d) of the Purchase Agreement. Without
limiting the provisions of Section 6.2, the Founders hereby agree to execute
such additional documents and to provide AAMAC or its transfer agent with any
further assurances as may be necessary to effect the cancellation or Transfer of
the Cancellation Shares.

      Section 7.2 Termination Fee Securities.

      (a) As provided for in Section 7.3 of the Purchase Agreement, upon the
occurrence of the events set forth therein, the Founders shall Transfer to
Halcyon Partner Vehicle 50% of the Founders' Common Shares (the "Termination Fee
Securities") set out on Exhibit B hereto; provided that actual title to the
Termination Fee Securities shall Transfer only at such moment when such shares
are releasable from escrow pursuant to the Escrow Agreement (without amendment
or waiver thereof).

      (b) Upon the occurrence of the event triggering the right of Halcyon
Partner Vehicle to receive the Termination Fee Securities, the Founders shall
relinquish to Halcyon Partner Vehicle all rights (other than those expressly
limited by the existence of the Escrow Agreement) to the Termination Fee
Securities, and Halcyon Partner Vehicle shall be entitled to all distributions,
dividends, voting rights, economic rights and liquidation rights thereon. Each
Founder hereby grants his proxy to Halcyon Partner Vehicle to exercise all of
such Founder's voting rights in the Termination Fee Securities during such
period that Halcyon Partner Vehicle shall be entitled to the voting rights
thereto and the Termination Fee Securities remain in escrow. In connection
therewith the Halcyon Partner Vehicle hereby agrees to vote all Termination Fee
Securities in accordance with the votes cast by the holders of the IPO shares
(as defined in the Letter Agreements) in the event that AAMAC solicits approval
of its stockholders of an Initial Business Combination (as defined in the Letter
Agreements) and acknowledges that the Termination Fee Securities will not
participate in any liquidation distribution if the company fails to consummate
an Initial Business Combination and waives any rights in connection therewith.
With respect to cash dividends on the Termination Fee Securities during the
period that it remains in escrow, the Founders shall cause the full amount of
such cash dividends to be delivered to Halcyon Partner Vehicle or the partners
in the Halcyon Partner Vehicle within two Business Days of such cash dividend
being paid to the Founders by the escrow agent. Until the termination of the
escrow period and delivery of title to the Termination Fee Securities to Halcyon
Partner Vehicle, the Founders shall not Transfer the Termination Fee Securities.

      (c) AAMAC and the Founders shall take all necessary steps to ensure that
the Termination Fee Securities and all distributions and dividends thereon are
each delivered to Halcyon Partner Vehicle at the earliest possible time,
provided that in no event shall such

                                       8
<PAGE>

delivery occur later than two Business Days after such distributions and
dividends are received by the Founders.

      Section 7.3 Adjustments to Prevent Dilution. In the event of a stock
dividend or distribution, or any change in the securities of AAMAC by reason of
any stock dividend, split-up, reclassification, recapitalization, combination or
the exchange of shares, the terms "Founders' Common Shares", "Sponsors'
Warrants", "Founders' Securities," "AAMAC Common Stock" and/or "Termination Fee
Securities" shall be deemed to refer to and include the Founders' Common Shares,
Sponsors' Warrants, Founders' Securities, AAMAC Common Stock and/or Termination
Fee Securities, as well as all such stock dividends and distributions and any
shares into which or for which any or all of the Founders' Common Shares,
Sponsors' Warrants, Founders' Securities, AAMAC Common Stock and/or Termination
Fee Securities may be changed or exchanged.

                                  ARTICLE VIII

                                   TERMINATION

      Section 8.1 Termination. This Agreement shall terminate, and no party
shall have any rights or obligations hereunder and this Agreement shall become
null and void and have no further effect upon the first to occur of (a) the
Closing Date and (b) the termination of the Purchase Agreement pursuant to
Article VII of the Purchase Agreement. Nothing in this Section 8.1 shall relieve
any party of liability for breach of this Agreement.

      Section 8.2 Survival. If this Agreement is terminated pursuant to Section
8.1, this Agreement shall become void and of no further force and effect, except
for the provisions set forth in Sections 7.2 and 7.3 and Article IX.

                                   ARTICLE IX

                               GENERAL PROVISIONS

      Section 9.1 Amendments. No amendment, modification, termination, or waiver
of any provision of this Agreement, and no consent to any departure by any
Founder or Halcyon Representative from any provision of this Agreement, shall be
effective unless it shall be in writing and signed and delivered by such Founder
and Halcyon Representative, and then it shall be effective only in the specific
instance and for the specific purpose for which it is given. Additionally, the
Escrow Agreement shall not be amended without Halcyon Representative's consent.

      Section 9.2 Notices. All notices, requests, claims, demands and other
communications required or permitted to be given under the Agreement shall be in
writing and shall be deemed effectively given (a) upon personal delivery to the
party to be notified; (b) when received when sent by e-mail or fax by the party
to be notified; provided, however, that notices given by e-mail or fax shall not
be effective unless either (i) a duplicate copy of such e-mail or fax notice is
promptly given by one of the other methods described in this Section 9.2, or
(ii) the receiving party delivers a written confirmation of receipt for such
notice either by e-mail, fax or any other

                                       9
<PAGE>

method described in this Section 9.2; (c) one Business Day (or three Business
Days in the case of notices to be received outside of the United States) after
deposit with a reputable overnight courier, prepaid for overnight delivery and
addressed as set forth in (d), provided that the sending party receives a
confirmation of delivery from the overnight courier service; or (d) three
Business Days after deposit with the U.S. Post Office, Royal Mail or other
governmental postal service, postage prepaid, registered or certified with
return receipt requested and addressed to the party to be notified at the
address indicated for such party below, or at such other address as such party
may designate by 10 days' advance written notice to the other parties given in
the foregoing manner.

      Section 9.3 Interpretation. When a reference is made in this Agreement to
Sections or Articles, such reference shall be to a Section or Article of this
Agreement unless otherwise indicated. The headings contained in this Agreement
are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. Wherever the words "include", "includes" or
"including" are used in this Agreement, they shall be deemed to be followed by
the words "without limitation". The term "it" when used as a reference to a
Founder which is an individual shall mean his or her, as appropriate.

      Section 9.4 Remedies Cumulative. All rights, powers and remedies provided
in this Agreement or otherwise available in respect hereof at law or in equity
shall be cumulative and not alternative, and the exercise of any thereof by any
party shall not preclude the simultaneous or later exercise of any other right,
power or remedy by such party.

      Section 9.5 Waivers. Except as otherwise specifically provided in this
Agreement, no Action taken pursuant to this Agreement, including any
investigation by or on behalf of any party, shall be deemed to constitute a
waiver by the party taking such Action of compliance with any representations,
warranties, covenants or agreements contained in this Agreement. The waiver by
any party hereto of a breach of any provision contained in this Agreement shall
not operate or be construed as a waiver of any prior or subsequent breach of the
same or any other provision contained in this Agreement.

      Section 9.6 Severability. Any term or provision of this Agreement which is
invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be
ineffective to the extent of such invalidity or unenforceability without
rendering invalid or unenforceable the remaining terms and provisions of this
Agreement or affecting the validity or enforceability of any of the terms or
provisions of this Agreement in any other jurisdiction. If any provision of this
Agreement is so broad as to be unenforceable, the provision shall be interpreted
to be only so broad as is enforceable.

      Section 9.8 Governing Law. This Agreement shall be governed by, and
construed in accordance with, the laws of the State of New York (without
reference to choice of law principles).

      Section 9.9 Entire Agreement. This Agreement embodies the entire agreement
and understanding of the Founders and Halcyon Representative and supersedes all
prior agreements or understandings, with respect to the subject matter of this
Agreement.

                                       10
<PAGE>

      Section 9.10 Fees and Expenses. Subject to the provisions of Section 8.6
of the Purchase Agreement, all costs and expenses incurred in connection with
this Agreement shall be paid by the party incurring such expenses.

      Section 9.11 Legal Counsel. The Founders acknowledge that they have each
had the opportunity to consult with their own attorneys prior to entering into
this Agreement.

      Section 9.12 Specific Performance; Enforcement. Each of the parties hereto
recognizes and acknowledges that a breach by it of any covenants or agreements
contained in this Agreement will cause the other party to sustain damages for
which it would not have an adequate remedy at law for money damages, and
therefore, each of the parties hereto agrees that in the event of any such
breach the aggrieved party shall be entitled to the remedy of specific
performance of such covenants and agreements and injunctive and other equitable
relief in addition to any other remedy to which it may be entitled, at law or in
equity.

      Section 9.13 Consent to Jurisdiction.

      (a) Each of the parties hereby irrevocably and unconditionally submits to
the exclusive jurisdiction of (i) the courts of the State of New York sitting in
New York City and (ii) the United States District Court for the Southern
District of New York for the purposes of any Action arising out of or relating
to this Agreement, any provision hereof or thereof or the breach, performance,
validity or invalidity hereof or thereof. Each party agrees that service of any
process, summons, notice or document to the party at the address for notices
specified in Section 9.2 hereof, mailed by first class mail shall be effective
service of process upon such party for any Action brought against it in such
court with respect to any matters to which it has submitted to jurisdiction as
set forth above. Each of the parties irrevocably and unconditionally waives any
objection to the laying of venue of any Action arising out of or relating to
this Agreement, any provision hereof or thereof or the breach, performance,
validity or invalidity hereof or thereof in the courts referred to in this
section, and hereby further irrevocably and unconditionally waives and agrees
not to plead or claim in any such court that any such Action brought in any such
court has been brought in an inconvenient forum. Notwithstanding the foregoing,
the parties agree that a final judgment in any Action or proceeding so brought
shall be conclusive and may be enforced by suit on the judgment in any
jurisdiction or in any other manner provided in law or in equity.

      (b) EACH OF THE PARTIES IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN
ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR
OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF THE
PARTIES IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE OR ENFORCEMENT THEREOF.

      Section 9.14 Counterparts: Facsimile. This Agreement maybe executed in
counterparts, all of which shall be considered one and the same agreement, and
shall become effective when counterparts have been signed by each of the parties
and delivered to the other parties, it being understood that all parties need
not sign the same counterpart. This Agreement may be executed by facsimile or
portable document format (pdf) signatures of the parties hereto.

                           [SIGNATURE PAGES TO FOLLOW]

                                       11
<PAGE>

      IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by
the duly authorized officers of the parties as of the date written above.

                               HALCYON EMPLOYEES LP
                               solely in its capacity as Halcyon Representative

                               ------------------------------------------------
                               Name:
                               Address:

                               with a copy to:
                               Igor Kirman
                               Wachtell, Lipton, Rosen & Katz
                               51 West 52nd Street
                               New York, New York  10019
                               Tel: +1 212 403 1000

                     (Signature Page to Founders' Agreement)

<PAGE>

                                            HANOVER OVERSEAS LIMITED

                                            By:
                                               ------------------------------
                                                 Name:
                                                 Title:
                                                 Address:

                                            STC INVESTMENT HOLDINGS LLC

                                            By:
                                               ------------------------------
                                                 Name:
                                                 Title:
                                                 Address:

                                            SOLAR CAPITAL, LLC

                                            By:
                                               ------------------------------
                                                 Name:
                                                 Title:
                                                 Address:

<PAGE>

                                            JAKAL INVESTMENTS, LLC

                                            By:
                                               ------------------------------
                                                 Name:
                                                 Title:
                                                 Address:

                                            ALTERNATIVE ASSET MANAGEMENT
                                            ACQUISITION CORPORATION

                                            By:
                                               ------------------------------
                                                 Name:
                                                 Title:
                                                 Address:

                                            By:
                                               ------------------------------
                                                 Mark D. Klein
                                                 Address:

                                            By:
                                               ------------------------------
                                                 David Hawkins
                                                  Address:

                                            By:
                                               ------------------------------
                                                 Steven A. Shenfeld
                                                  Address:

                                            By:
                                               ------------------------------
                                                 Bradford R. Peck
                                                 Address:

                                            By:
                                               ------------------------------
                                                 Frederick G. Kraegel
                                                 Address:

<PAGE>

                                                                       EXHIBIT A

            BENEFICIAL AND RECORD OWNERSHIP OF FOUNDERS' SECURITIES
            -------------------------------------------------------

Equity Interests of Founders

----------------------------------- ------------------------ -------------------
                                         AAMAC Common Stock      AAMAC Warrants
----------------------------------- ------------------------ -------------------
Hanover Overseas Limited                          2,910,938           1,067,250
----------------------------------- ------------------------ -------------------
STC Investment Holdings LLC                       3,881,250           1,423,000
----------------------------------- ------------------------ -------------------
Solar Capital, LLC                                1,293,750             712,000
----------------------------------- ------------------------ -------------------
Jakal Investments, LLC                              983,250             712,000
----------------------------------- ------------------------ -------------------
Mark D. Klein                                       970,312             355,750
----------------------------------- ------------------------ -------------------
David Hawkins                                        51,750                  --
----------------------------------- ------------------------ -------------------
Steven A. Shenfeld                                  155,250             355,000
----------------------------------- ------------------------ -------------------
Bradford R. Peck                                     51,750                  --
----------------------------------- ------------------------ -------------------
Frederick G. Kraegel                                 51,750                  --
----------------------------------- ------------------------ -------------------
TOTAL                                            10,350,000           4,625,000
----------------------------------- ------------------------ -------------------

<PAGE>

                                                                       EXHIBIT B

               CANCELLATION SHARES AND TERMINATION FEE SECURITIES
               --------------------------------------------------

----------------------------------- ------------------------ -------------------
                                                                Termination Fee
                                        Cancellation Shares          Securities
                                          (per Section 7.1)   (per Section 7.2)
----------------------------------- ------------------------ -------------------
Hanover Overseas Limited                            725,625           1,455,469
----------------------------------- ------------------------ -------------------
STC Investment Holdings LLC                         967,500           1,940,625
----------------------------------- ------------------------ -------------------
Solar Capital, LLC                                  322,500             646,875
----------------------------------- ------------------------ -------------------
Jakal Investments, LLC                              245,100             491,625
----------------------------------- ------------------------ -------------------
Mark D. Klein                                       241,875             485,156
----------------------------------- ------------------------ -------------------
David Hawkins                                        12,900              25,875
----------------------------------- ------------------------ -------------------
Steven A. Shenfeld                                   38,700              77,625
----------------------------------- ------------------------ -------------------
Bradford R. Peck                                     12,900              25,875
----------------------------------- ------------------------ -------------------
Frederick G. Kraegel                                 12,900              25,875
----------------------------------- ------------------------ -------------------
TOTAL                                             2,580,000           5,175,000
----------------------------------- ------------------------ -------------------

<PAGE>

                                                                       EXHIBIT C

                       FORM OF ESCROW AGREEMENT AMENDMENT
                       ----------------------------------

                 Alternative Asset Management Acquisition Corp.
                         590 Madison Avenue, 35th Floor
                               New York, NY 10024

                                 March __, 2008

Continental Stock Transfer & Trust Company
17 Battery Place
New York, NY 10004

Ladies and Gentlemen:

      Reference is made to that certain Escrow Agreement, dated as of August 1,
2007 (the "Escrow Agreement"), by and among Alternative Asset Management
Acquisition Corp. (the "Company"), the initial stockholders of the Company named
therein and Continental Transfer & Trust Company. Capitalized terms used and not
otherwise defined herein shall have the meanings set forth in the Escrow
Agreement.

      The Company is considering entering into a definitive agreement with
respect to a potential Initial Business Combination. In connection with such
Initial Business Combination, the Initial Stockholders intend to enter into a
Founders' Voting and Support Agreement (the "Founders Agreement") which will
provide that the Initial Stockholders forfeit a certain number of Escrow Shares
upon consummation of the Initial Business Combination. Notwithstanding anything
to the contrary set forth in the Escrow Agreement, upon delivery by the Company
to the Escrow Agent of a copy of the Founders Agreement which has been executed
and delivered by the Initial Stockholders and notice from the Company that the
Initial Business Combination has been consummated, the Escrow Agent shall
deliver to the Company for cancellation, at no cost, the number of Escrow Shares
set forth in Exhibit B to the Founders Agreement under the column entitled
"Cancellation Shares."

      Except as set forth herein, the Escrow Agreement is not amended or
modified in any respect and remains in full force and effect. If you are in
agreement with the foregoing, please execute this letter agreement where
indicated below and return it to the address set forth above.

                            [Signature Pages Follow]exv10w36

 

Exhibit 10.36

Manufacturing and Supply Agreement

     This Manufacturing and Supply Agreement (the “Agreement”), effective as of November
2, 2007 (the “Effective Date”), is made by and between Alexza Pharmaceuticals, Inc. of
1020 East Meadow Circle, Palo Alto, CA 94303 (“Alexza”), and Autoliv ASP, Inc. of 3350
Airport Road, Ogden, UT 84405 (“Autoliv”).

Recitals

     A. Under a Development Agreement between the parties dated October 3, 2005
(“Development Agreement”), Autoliv developed a chemical heat package for Alexza; and

     B. Autoliv and Alexza desire that Autoliv manufacture such chemical heat packages for
Alexza; subject to the terms and conditions set forth herein.

     In consideration of the respective covenants, representations, warranties and
agreements set forth herein, and intending to be legally bound, the parties hereby agree as
follows:

ARTICLE 1

Definitions

     As used in this Agreement, capitalized terms will have the meanings set forth below.

     1.1 “Affiliate” means with respect to an entity, a person, corporation or other entity that,
directly or indirectly, through one or more intermediaries, controls, is controlled by or is under
common control with that entity. For Autoliv, this Agreement binds only Autoliv ASP, Inc.

     1.2 “Alexza Field” means the areas of prevention, treatment, management, monitoring or
diagnosis of illness or disease through the use of devices incorporating a chemical heat package,
including subsequent generations or similar devices used to aerosolize drugs.

     1.3 “Alexza Indemnitees” has the meaning given to such term in Section 11.2.

     1.4 “Alexza IP” has the meaning given to such term in Section 9.4.

     1.5 “Annual Purchase Order” has the meaning given to such term in Section 3.3.

     1.6 “Autoliv Field” means the areas outside the Healthcare Field.

     1.7 “Autoliv Indemnitees” has the meaning given to such term in Section 11.1.

     1.8 “Autoliv IP” has the meaning given to such term in Section 9.3.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

     1.9 “Autoliv Patents” means all patents and patent applications listed on Exhibit F and all
Foreign Counterparts continuations, continuations-in-part, requests for continuing examination
(RCEs), divisionals, substitutions, re-examinations, reissues, extensions, registrations and
supplementary or complementary certificates of such patents and patent applications and any patents
that issue therefrom.

     1.10 “Background Technology” has the meaning given to such term in Section 9.1.

     1.11 “Build Forecast” has the meaning given to such term in Section 3.4.

     1.12 “Chemical Heat Package” means Alexza’s proprietary CPD (Commercial Product Development)
heat pack that consists of a chemical heat source sealed within an inert, stainless steel substrate
and is further described on Exhibit A attached hereto or subsequent mutually agreed revisions
thereto, but excluding any subsequent generations of the Chemical Heat Package.

     1.13 “Confidential Information” means all information disclosed by a party hereto to the other
party pursuant to the Development Agreement, the Consultant Services Agreement, the Mutual CDA or
this Agreement. In particular, Confidential Information of Alexza shall be deemed to include, but
is not limited to, the Alexza IP, information relating to the Specifications, the process used by
Autoliv to manufacture the Chemical Heat Packages, and Alexza’s research and development programs
and results, prototypes and products, clinical and preclinical data, trade secrets, business
strategy, patent applications, licenses, suppliers’ and manufacturers’ identities, product and
marketing strategy, customers, market data, personnel and consultants, and other technical or
business information.

     1.14 “Consultant Services Agreement” means the Consultant Services Agreement between the
parties dated as of December 17, 2004.

     1.15 “Development Agreement” has the meaning given to such term in the recitals.

     1.16 “Disclosing Party” has the meaning given to such term in Section 12.2.

     1.17 “ECR” has the meaning given to such term in Section 6.1.

     1.18 “Finished Product” means a device containing a Chemical Heat Package manufactured by
Autoliv and delivered by Autoliv to Alexza pursuant to this Agreement.

     1.19 “Foreign Counterparts” means foreign applications or issued foreign patents, which claim
priority from, or share common priority with, an identified United States patent or patent
application, and the inventions covered thereby.

     1.20 “Healthcare Field” means the areas of prevention, treatment, management, monitoring or
diagnosis of illness or disease.

     1.21 “Healthcare Product” has the meaning given to such term in Section 2.5(b).

     1.22 “Initial Term” means the period beginning on the Effective Date and ending on
December 31, 2012.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

     1.23 “Intellectual Property Rights” means all present and future worldwide trade secrets,
patents, patent applications, copyrights, mask works or other proprietary or property rights.

     1.24 “Joint IP” has the meaning given to such term in Section 9.5.

     1.25 “Key Personnel” has the meaning given to such term in Section 2.3(a).

     1.26 “Mandatory Engineering Change” means any change to the Specifications that is necessary
to ensure the safety of the Chemical Heat Packages and/or the conformance of the Chemical Heat
Packages with all applicable laws and regulations of any country, including laws (a) in effect as
of the date of delivery of the Chemical Heat Packages to Alexza, and (b) that require Alexza to
replace the Chemical Heat Packages in Finished Products already sold to distributors or customers.

     1.27 “Mutual CDA” means the Mutual Confidential Disclosure Agreement between the parties dated
as of November 3, 2004.

     1.28 “New Discoveries” means inventions, developments, improvements, enhancements or
modifications, whether or not patentable, that are conceived or developed or reduced to practice by
Alexza or Autoliv arising out of or in connection with Alexza or Autoliv’s performance under this
Agreement.

     1.29 “Operations Representative” has the meaning given to such term in Section 2.3(b).

     1.30 “Optional Engineering Change” means any change to the Specifications that is not a
Mandatory Engineering Change.

     1.31 “Pilot Production Line” means the low volume production line for the manufacture of the
Chemical Heat Packages that is located at Autoliv’s manufacturing site as of the Effective Date and
all post-Effective Date modifications thereof.

     1.32 “Purchase Date” means the date that is earliest of (a) December 31, 2011, (b) sixty (60)
days after the approval by the FDA of a New Drug Application filed by Alexza, or (c) sixty (60)
days after the effective date of termination of this Agreement pursuant to Section 10.2

     1.33 “Quality Terms” has the meaning given to such term in Section 7.1.

     1.34 “Receiving Party” has the meaning given to such term in Section 12.2.

     1.35 “Release” or “Actual Order” shall mean a firm order or demand issued by Alexza to Autoliv
specifying the quantity of Chemical Heat Packages ordered, delivery dates and delivery destination.

     1.36 “Second Generation Agreement” has the meaning given to such term in
Section 2.6.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

     1.37 “Second Generation Package” means a heating substrate for the vaporization of a drug
that: (a) consists of a chemical heat source sealed within an inert, stainless steel substrate and
(b) is based upon and represents an improvement to, or modification of, the Chemical Heat Package
such that it does not conform with description set forth in Exhibit A or subsequent mutually agreed
revisions thereto.

     1.38 “Specifications” means the minimum specifications for the Chemical Heat Packages set
forth in Exhibit B attached hereto, as may be amended from time to time in accordance with Article
6.

     1.39 “Strategic Forecast” has the meaning given to such term in Section 3.2.

     1.40 “Third Party” means any party other than Alexza, Autoliv or an Affiliate of Alexza or
Autoliv.

ARTICLE 2

Manufacturing

     2.1 Manufacture. The parties agree that Autoliv shall manufacture, assemble, and test, the
Chemical Heat Packages in conformance with the Specifications and in compliance with the terms and
conditions of this Agreement (including the Quality Terms), for sale solely to Alexza. Such
manufacture, assembly and testing shall be performed solely in one of Autoliv’s Northern Utah
facilities unless (a) the parties agree upon an alternative Autoliv location or (b) Autoliv closes
all of its Northern Utah facilities after at least three (3) years written notice to Alexza, which
notice shall specify the location at which Autoliv plans to perform such activities after such
closure, and Alexza does not terminate this Agreement in accordance with Section 10.4(c)(iii).
Autoliv will provide all of the manufacturing equipment necessary to manufacture the Chemical Heat
Packages in accordance with the Specifications and the terms and conditions of this Agreement
(including the Quality Terms).

     2.2 Non-delegable Responsibility. Each party’s rights and obligations under this Agreement
may not be subcontracted to any Third Party, without the prior written consent of the other party.

     2.3 Autoliv Personnel

          (a) Key Personnel. The names, positions, and roles of Autoliv’s key personnel who
will be involved in the manufacture, assembly, or testing of the Chemical Heat Packages are set
forth in Exhibit D (“Key Personnel”). Autoliv shall provide any information reasonably requested
by Alexza with respect to such Key Personnel and their duties. If Autoliv removes or reassigns any
Key Personnel, Autoliv shall promptly notify Alexza.

          (b) Operations Representative. Exhibit D sets forth the name of Autoliv’s project
representative who shall have overall responsibility for the Pilot Production Line and the
manufacture, assembly, and testing of the Chemical Heat Packages provided under this Agreement
(“Operations Representative”).

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

     2.4 Meetings. The parties shall meet at least annually, or whenever necessary by mutual
agreement, to discuss issues related to this Agreement including design, performance, quality,
changes and delivery. The topics may include, for example, Autoliv’s compliance or non-compliance
with any Specifications, adherence to delivery schedule, Pilot Production Line or any other
production line issues or modifications, capacity plans, forecasts, or other requirements of this
Agreement (including the Quality Terms). The parties shall sign the meeting minutes to confirm
their respective agreements, commitments, approvals, and obligations related to specific items or
issues.

     2.5 Exclusivity.

          (a) During the Initial Term and any extension(s) of the term of this Agreement by mutual
written agreement, Alexza shall not, either alone or with or through any Affiliate or Third Party,
manufacture, have manufactured or purchase Chemical Heat Packages from any Third Party, provided
that Autoliv has not materially breached any term or condition of this Agreement, including the
requirement that the Chemical Heat Packages conform to the Specifications and the quality
conditions set forth in the Quality Terms. Autoliv agrees that Alexza shall not be in breach of
the foregoing sentence if Alexza (i) Alexza engages a Third Party manufacturer to manufacture and
test Chemical Heat Packages, so long as such Third Party manufacturer does not sell Chemical Heat
Packages to Alexza during the exclusivity period set forth in the preceding sentence, or (ii)
discloses Autoliv IP, Joint IP or Intellectual Property rights owned by Autoliv pursuant to the
Development Agreement (“Development IP”) to a Third Party manufacturer that is reasonably necessary
for such Third Party to manufacture and test the Chemical Heat Packages, so long as such Third
Party Manufacturer agrees not to exploit the Autoliv IP, Joint IP or Development IP outside the
Healthcare Field or in any other way inconsistent with this Agreement

          (b) During the Initial Term and any extension(s) of the term of this Agreement by mutual
written agreement, provided that Alexza has not materially breached any term or condition of this
Agreement, Autoliv shall not, either alone or with or through any Affiliate or Third Party,
manufacture or commercialize Chemical Heat Packages (except for Autoliv’s manufacture, assembly and
testing of Chemical Heat Packages for sale to Alexza pursuant to this Agreement) or any other
device or component for use in the Healthcare Field that utilizes any Alexza IP, as defined in this
Agreement, unless Alexza provides prior written consent for such activities. If Autoliv wishes to
develop, manufacture and commercialize a product in the Healthcare Field (a “Healthcare Product”)
that does not utilize any Alexza IP, it may do so, provided that the Healthcare Product is not
competitive with the Chemical Heat Packages or Finished Products or any other products that Alexza
is then marketing or then has in clinical or pre-clinical development.

     2.6 Right of Negotiation. Prior to engaging a Third Party to assist Alexza in the commercial
manufacture of a Second Generation Package, Alexza shall notify Autoliv in writing and offer
Autoliv the opportunity to negotiate the terms and conditions of a separate agreement (the “Second
Generation Agreement”) whereby Autoliv would supply such Second Generation Package. If Autoliv
notifies Alexza in writing within thirty (30) days of Alexza’s notice that Autoliv is interested in
commercially supplying such Second Generation Package, the parties shall promptly initiate good
faith negotiations regarding the terms and conditions of the Second

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Generation Agreement with the goal of entering into the Second Generation Agreement within
ninety (90) days of Autoliv’s notice. If the parties fail to agree on the terms for the Second
Generation Agreement, Alexza may execute an agreement with a Third Party to commercially
manufacture the Second Generation Package and Alexza shall make the payments set forth in Section
5.6(a). For clarity, this Section 2.6 does not apply to or affect Alexza’s right to manufacture
for itself any and all Second Generation Packages.

ARTICLE 3

Chemical Heat Package Forecasting and Ordering

     3.1 Purchase Right. Autoliv agrees to sell and Alexza agrees to purchase the Chemical Heat
Packages in accordance with the terms of this Agreement.

     3.2 Strategic Forecast. On a quarterly basis, Alexza shall provide Autoliv with a written
rolling forecast of Alexza’s anticipated need for Chemical Heat Packages for each calendar quarter
during the following three (3) calendar years (“Strategic Forecast”). The Strategic Forecast is
not binding on Alexza and is provided by Alexza solely for capacity planning purposes. However, to
the extent Autoliv must order or commit to long-lead time materials, equipment, tooling or
components in order to have the ability to supply to Alexza the number of Chemical Heat Packages
specified in the Strategic Forecast, Alexza shall reimburse Autoliv, on the timetable agreed upon
by the parties when the items are determined to be unused, for any such unused materials,
equipment, tooling or components, provided that (a) Alexza approved the purchase thereof in writing
(which approval may be in meeting minutes signed by Alexza) and (b) on account of Alexza’s
commitments in Section 5.4, Alexza shall not have any obligation pursuant to this Section 3.2 to
reimburse Autoliv for equipment and tooling needed to supply up to ten million (10,000,000)
Chemical Heat Packages per year. Upon reimbursement by Alexza to Autoliv pursuant to this Section
3.2, Autoliv shall transfer to Alexza sole ownership of all such materials, equipment, tooling or
components.

     3.3 Annual Purchase Order. At least thirty (30) days before the beginning of each calendar
year, Alexza shall provide Autoliv with a written purchase order (“Annual Purchase Order”) that
specifies (i) the number of units of Chemical Heat Packages Alexza will purchase from Autoliv
during such calendar year; (ii) the fixed unit purchase price for such Chemical Heat Packages as
set forth on Exhibit C; (iii) the billing and ship-to addresses; and (iv) any special instructions
or other pertinent requirements. Alexza may update the billing and ship-to addresses during the
course of such year by written notice to Autoliv. Autoliv must accept or reject each Annual
Purchase Order within thirty (30) days after the receipt thereof, provided that it may not reject
any Annual Purchase Order unless (a) such Annual Purchase Order does not comply with the terms set
forth in subsections (i)-(iii) of this Section 3.3, or (b) the quantity ordered on such Annual
Purchase Order is a material increase over the quantities set forth for such calendar year in the
then-current Strategic Forecast. Upon Autoliv’s acceptance, each Annual Purchase Order shall be
binding on the parties, provided that Alexza is not obligated to accept more than 80% of the
quantity specified on such Annual Purchase Order.

     3.4 Build Forecast. On a weekly basis, Alexza shall provide Autoliv with a written or
electronic rolling forecast of Alexza’s anticipated weekly needs for Chemical Heat Packages for the
following thirteen (13) weeks (“Build Forecast”). The Build Forecast shall be binding

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

on Alexza solely to the extent specified in Section 3.3. The parties shall cooperate in
issuing manufacturing releases reflecting level loading at their respective plants. The parties
agree to exert all reasonable efforts to minimize excessive variations in volume demand. However,
if a Release issued by Alexza pursuant to Section 3.5 exceeds the relevant portion of the then
current Build Forecast by more than 20%, Autoliv shall be entitled to reasonable reimbursement,
subject to mutual agreement, for higher costs related to overtime, premium freight, expedited
tooling/equipment, scrap, labor inefficiencies, etc. required to manufacture such excess (i.e.
beyond 20%) quantities of Chemical Heat Packages. The piece price shall not be affected.

     3.5 Releases. Alexza shall issue periodic Releases, binding on the parties, electronically or
in writing for Chemical Heat Packages that specify the quantity of units ordered, delivery dates
(provided no delivery date shall be less than 10 days after the issuance of any Release),
destination, and any other relevant information.

ARTICLE 4

Delivery

     4.1 Delivery Schedule. Autoliv will deliver to Alexza the quantity of Chemical Heat Packages
specified in the applicable Release by the delivery date specified in the applicable Release. A
delivery will be considered on-time if it is delivered within plus or minus one (1) day after the
delivery date specified in the Release. In the event of any delays in the delivery of Chemical
Heat Packages, and without limiting Alexza’s other rights and remedies hereunder, Autoliv will
notify Alexza of such delay and work diligently to remedy such delay immediately. In the event of
a delay in delivery of more than one (1) day for reasons other than force majeure, Alexza may, at
its sole discretion, cancel, reschedule, or require fulfillment of the affected Release, provided
that if Alexza requires fulfillment of such Release, Autoliv shall (a) express deliver (at
Autoliv’s expense) the Chemical Heat Packages ordered under such Annual Purchase Order, and (b)
reimburse Alexza for any and all costs it incurred as a result of such delay. All deliveries shall
be DDU (Incoterms 2000) the ship-to address specified in the Annual Purchase Order. Autoliv will
comply with Alexza’s requested means of shipping the Chemical Heat Packages and will not separately
charge Alexza (in addition to the purchase price specified in Section 5.1) for any shipping,
handling or other transportation-related costs incurred by Autoliv for delivery of Chemical Heat
Packages within the continental United States. Autoliv will not send partial or incomplete
shipments of any Release except with Alexza’s prior written consent. Chemical Heat Packages shipped
to Alexza more than two (2) days in advance of the applicable delivery date, or any partial or
incomplete shipments sent without Alexza’s prior written consent, may be returned to Autoliv at
Autoliv’s expense. No payment or other obligations of Alexza will accrue on Chemical Heat Packages
before the applicable delivery date for deliveries made by Autoliv in advance of such delivery
date, or on partial or incomplete shipments, unless Alexza has accepted the Chemical Heat Packages.

     4.2 Packaging Requirements. All Chemical Heat Packages delivered by Autoliv shall be in
packaging that complies with specifications set forth in Drawing Number 6088341 and subsequent
written, mutually agreed modifications thereto.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

ARTICLE 5

Purchase Prices; Royalties; Payment

     5.1 Purchase Prices.

          (a) Purchase Prices During the Initial Term. Subject to the terms and conditions of
this Agreement including without limitation Section 5.2, for each Chemical Heat Package delivered
by Autoliv pursuant to Section 4.1, Alexza will, during the Initial Term, pay Autoliv the purchase
price for such Chemical Heat Package specified in Exhibit C.

          (b) Purchase Prices After the Initial Term. For each calendar year after the Initial
Term, the parties will initiate negotiations three (3) years in advance of such calendar year, to
mutually agree, in writing and within six (6) months after such initiation of negotiations, upon
the purchase prices for the Chemical Heat Packages for such calendar year. The parties will
reflect their agreement by modifying Exhibit C. All such negotiations will be conducted in good
faith. Subject to the terms and conditions of this Agreement, Alexza will, for each calendar year
after the Initial Term for which the parties have agreed upon a purchase price in accordance with
this Section, pay Autoliv the agreed purchase price for such calendar year for Chemical Heat
Packages delivered by Autoliv pursuant to Section 4.1 in such calendar year.

     5.2 Purchase of Pilot Production Line. Autoliv acknowledges that, as of the Effective Date,
the Pilot Production Line is jointly owned by the parties. Autoliv shall purchase Alexza’s rights,
title, and interest in and to the Pilot Production Line by providing the first one hundred thousand
(100,000) units of the Chemical Heat Packages delivered to and accepted by Alexza pursuant to this
Agreement at no charge to Alexza. Chemical Heat Packages delivered to Alexza under this Agreement
shall only count toward such total if they meet the Specifications and the other terms and
conditions of this Agreement and were delivered pursuant to Actual Orders submitted by Alexza.
Such Chemical Heat Packages shall be included in the total number of Chemical Heat Packages
purchased by Alexza in the applicable calendar year when determining the per unit purchase price of
other Chemical Heat Packages delivered to Alexza during such calendar year. Notwithstanding
anything contained in this Section 5.2, Alexza’s rights, title, and interest in and to the Pilot
Production Line shall not be considered assigned or transferred to Autoliv until Autoliv has
delivered one hundred thousand (100,000) units of the Chemical Heat Packages to Alexza without
charge in accordance with this Section 5.2.

     5.3 Purchase Price Payments. Autoliv shall invoice Alexza for all units of the Chemical Heat
Packages ordered pursuant to a Release only after actual delivery of such Chemical Heat Packages to
Alexza. Alexza will pay Autoliv the undisputed amount for such Chemical Heat Packages within
forty-five (45) days after receipt of Autoliv’s applicable invoice, provided that the parties will
attempt, in good faith, to resolve any disputed invoices within 30 days of the original date when
the payment was due. Within thirty (30) days after the end of each calendar year, the parties will
review the number of units of Chemical Heat Packages actually ordered in such calendar year
pursuant to Releases (or as required pursuant to Section 3.3) and make any payment necessary for
the per-unit purchase price paid by Alexza to be the price that corresponds with such number of
units.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

     5.4 Expense Reimbursement. The parties acknowledge that Autoliv has made a

substantial commitment pursuant to the terms of the Development Agreement and will make a
substantial investment in capital equipment, personnel and facilities to provide one or more
production lines with a total capacity of ten million (10,000,000) Chemical Heat Packages per year
pursuant to the terms of this Agreement. Upon the Purchase Date, Alexza will pay Autoliv twelve
million dollars ($12,000,000), provided that (i) if prior to the Purchase Date Alexza has
terminated this Agreement pursuant to Section 10.4(a) or 10.4(c), Alexza shall instead pay Autoliv
on the Purchase Date the then depreciated book value of the equipment and tooling of Autoliv used
in the production of up to ten million (10,000,000) Chemical Heat Packages per year and (ii) if
prior to the Purchase Date Autoliv has terminated this Agreement pursuant to Section 10.4(a) or
10.4(b), Alexza shall instead pay Autoliv on the Purchase Date an amount equal to Autoliv’s cost
for equipment and tooling of Autoliv used in the production of up to ten million (10,000,000)
Chemical Heat Packages per year plus a reasonable charge for Autoliv’s employees and facilities
dedicated to such production of Heat Packages, which amount shall not exceed twelve million dollars
($12,000,000). At least thirty (30) days before the Purchase Date, Autoliv shall notify Alexza in
writing of the amount payable by Alexza to Autoliv under sub-clause (i) or (ii), as applicable.
Upon payment of the applicable amount set forth above, Alexza shall own all right, title and
interest in all of Autoliv’s equipment and tooling used in the production and testing of Chemical
Heat Packages, including the equipment and tooling related to the Pilot Production Line, free and
clear of any and all encumbrances, liens and security interests.

     5.5 Taxes. The purchase price for the Chemical Heat Packages shall be inclusive of, and
Autoliv agrees to pay, and will indemnify and hold Alexza harmless from the payment of, all sales,
use, excise, value added or similar tax, as well as the collection or withholding thereof,
including penalties and interest and all government permits or license fees and all customs, duty,
tariff and similar fees levied upon the delivery of the Chemical Heat Packages to Alexza, and any
costs associated with the collection of any of the foregoing items, provided that Alexza provides
Autoliv with copies of any applicable tax exemption certificates.

     5.6 Royalty Payments and Reports.

          (a) If Alexza manufactures Second Generation Packages or, subject to Section 2.6, executes an
agreement with a Third Party to manufacture Second Generation Packages, Alexza shall pay Autoliv
the following amounts, as applicable, within sixty (60) days of the end of each calendar quarter:
(i) [ * ] of the direct costs (as defined below) for Alexza’s manufacture of Second Generation
Packages or (ii) [ * ] of the purchase price (not including any taxes, shipping costs or handling
fees) Alexza pays to a Third Party manufacturer for supplying the Second Generation Packages. For
the purpose of this Section 5.6(a), “direct costs” shall mean Alexza’s costs of direct labor, bill
of materials, and consumables needed to produce and approve for use Second Generation Packages.

          (b) Any tax which Alexza is required to pay or withhold from royalty payments to be made to
Autoliv shall be deducted from the amount otherwise due, provided that, in regard to any such
deduction, Alexza shall give Autoliv such assistance as may be reasonably necessary to enable or
assist Autoliv to claim exemption therefrom or a reduction thereof and shall provide Autoliv with
an official tax certificate as soon as reasonably possible.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

     5.7 Currency. All references to “dollars” or “$” means the legal currency of the United
States. All payments made pursuant to this Agreement will be in U.S. dollars, unless otherwise
mutually agreed in advance by the parties in writing.

     5.8 Audits.

          (a) Alexza, will have the right, during normal business hours and upon at least thirty (30)
days prior notice, to have an independent audit firm selected by Alexza and reasonably acceptable
to Autoliv, audit Autoliv’s records for the preceding three (3) years relating to Autoliv’s
activities pursuant to this Agreement in order to verify the amount for which Alexza must (i)
reimburse Autoliv in accordance with Section 3.2 or pay Autoliv in accordance with Section 5.4(i)
or (ii), as applicable. In addition, Alexza will have the right to conduct quality reviews in
accordance with the terms and conditions of the Quality Terms

          (b) Autoliv, will have the right, during normal business hours and upon at least thirty (30)
days prior notice, to have an independent audit firm selected by Autoliv and reasonably acceptable
to Alexza, audit Alexza’s records for the preceding three (3) years relating to Alexza’s
manufacture or purchase of Second Generation Packages or Chemical Heat Packages in order to verify
the accuracy of Alexza’s royalty payments provided pursuant to Section 5.6(a) or 10.5(b).

          (c) The party whose records are being inspected shall make those records available for
inspection by the auditor during regular business hours, solely for the verification purposes
specified in this Section 5.8. Records covering any particular period may be inspected or audited
only once. The report prepared by such independent accountant, a copy of which shall be sent or
otherwise provided to the audited party at the same time it is sent or otherwise provided to the
party requesting the audit, shall contain the conclusions of such independent accountant regarding
the audit and will specify that the amounts paid were correct, or, if incorrect, the amount of any
underpayment or overpayment. If such report shows any underpayment or overpayment, then, within
thirty (30) days after the parties’ receipt of such report, the appropriate party shall remit to
the other party the amount needed to eliminate such underpayment or overpayment. The audit will be
conducted at the auditing party’s expense unless the audit reveals a discrepancy of five percent
(5%) or more of the amount previously reported by the audited party to the other party for the
audited period, in which case the audited party shall pay the reasonable costs for such audit.

          (d) Any confidential or proprietary information of the audited party disclosed to auditing
party in the course of the inspection or audit shall be subject to auditing party’s confidentiality
obligations under this Agreement. Any confidential or proprietary information of audited party
disclosed to the independent audit firm in the course of the audit will be subject to a
confidentiality agreement reasonably acceptable to the auditing party to be signed by the audited
and such independent audit firm.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

ARTICLE 6

Change Orders

     6.1 Optional Chemical Heat Package Changes. Optional Engineering Change

orders may be initiated from time to time in accordance with this Section 6.1. If Alexza
proposes an Optional Engineering Change, Alexza will prepare and submit to Autoliv an Engineering
Change Request (“ECR”) detailing the changes in the Chemical Heat Package desired by Alexza.
Within thirty (30) days after receipt of an ECR, Autoliv will prepare a written response to such
ECR detailing at a minimum: (i) the technical specifications for the proposed change; (ii) the
purchase price for the modified Chemical Heat Package; (iii) the amount of time required to
implement such change; and (iv) any anticipated changes to the lead time associated with purchasing
the modified Chemical Heat Package. Autoliv may also propose Optional Engineering Changes to
Alexza in writing, detailing the same information required above. If Alexza determines, following
receipt of Autoliv’s proposal or response, as applicable, that the proposed Optional Engineering
Change order is not acceptable, then Autoliv shall not make the Optional Engineering Change. If
Alexza determines, following receipt of Autoliv’s proposal or response, as applicable, that the
proposed Optional Engineering Change order is acceptable, then Autoliv shall make the Optional
Engineering Change and Alexza shall pay the mutually agreed purchase price for Chemical Heat
Packages manufactured with such Option Engineering Change.

     6.2 Mandatory Engineering Change. In the event that Autoliv or Alexza become aware of the
necessity to implement a Mandatory Engineering Change, such party shall immediately notify the
other party in writing, specifying the cause for the Mandatory Engineering Change and the specific
changes to the Chemical Heat Package necessary to implement the Mandatory Engineering Change.
Autoliv shall promptly provide Alexza with a reasonable schedule to implement the Mandatory
Engineering Change and the reasonable purchase price for the modified Chemical Heat Package,
provided that any increases in purchase price shall only reflect the additional costs that Autoliv
incurs that are specifically related to making the Mandatory Engineering Change. The parties shall
jointly assess the impact on prior or future deliveries of Chemical Heat Packages. Based on that
assessment, the parties shall negotiate the schedule for incorporating any Mandatory Engineering
Change as well as any changes in delivery schedules, prices, etc. If a dispute arises between the
parties with respect to a Mandatory Engineering Change, senior officers of the parties shall
attempt, in good faith, to resolve the dispute in a reasonable period of time. If such attempts
are not successful, either party may submit the dispute to a competent court for resolution in
accordance with Section 13.9.

ARTICLE 7

Quality Terms; Improvements; Failure Analysis; Disaster Recovery

     7.1 Quality Terms. The parties shall apply and be bound by the quality procedures for all
Chemical Heat Packages delivered pursuant to this Agreement as set forth in Exhibit E (“Quality
Terms”).

     7.2 Failure Analysis. Autoliv shall, at no additional cost to Alexza conduct a failure
analysis as set forth in the Quality Terms on all defective Chemical Heat Packages returned by
Alexza to Autoliv, to determine the cause of failure, if any.

     7.3 Disaster Recovery Plans. Autoliv shall promptly (but in no event later than seventy-two
(72) hours after its occurrence) notify Alexza in writing of any disaster or event that

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

may adversely affect the quality or delivery to Alexza of the Chemical Heat Packages. Without
limiting the foregoing, upon Alexza’s request, Autoliv will provide to Alexza its Disaster Recovery
Plan or equivalent.

ARTICLE 8

Representations and Warranties

     8.1 Mutual Representations and Warranties. Each party hereby represents and warrants:

          (a) Corporate Power. Such party is duly organized and validly existing under the laws of the
state or nation of its incorporation and has full corporate power and authority to enter into this
Agreement and to carry out the provisions hereof.

          (b) Due Authorization. Such party is duly authorized to execute and deliver this Agreement
and to perform its obligations hereunder.

          (c) Binding Agreement. This Agreement is a legal and valid obligation binding upon it and is
enforceable in accordance with its terms. The execution, delivery and performance of this
Agreement by such party does not conflict with any agreement, instrument or understanding, oral or
written, to which it is a party or by which it may be bound, nor violate any law or regulation of
any court, governmental body or administrative or other agency having authority over it.

     8.2 Representations and Warranties Concerning Chemical Heat Packages. Autoliv represents and
warrants to Alexza that each Chemical Heat Package supplied to Alexza under this Agreement will (a)
be new and unused and be free from any security interest or any other lien, claim or other
encumbrance; (b) conform to the Specifications; and (c) be manufactured and packaged in compliance
with this Agreement, the Quality Terms and the TS16949 certification. Without limiting any other
rights or remedies of Alexza under this Agreement, Autoliv will, at Autoliv’s option, either (i)
repair the affected Chemical Heat Package to conform to the warranty; (ii) replace such Chemical
Heat Package with a conforming Chemical Heat Package; or (iii) provide a credit or refund to Alexza
of the payment made by Alexza for such Chemical Heat Package, in each case at Autoliv’s expense.
Unless Autoliv reasonably demonstrates that a returned Chemical Heat Package was conforming when
originally delivered to Alexza, Autoliv shall pay the costs of all shipping and insurance of the
item (including, upon repair or replacement, return of the same or replacement item to the original
location) and assume the risk of loss during shipping. All replaced or repaired Chemical Heat
Packages under this Section 8.2 shall be subject to the same warranties as provided herein and all
replacement Chemical Heat Packages shall be new.

     8.3 Representations and Warranties Concerning Intellectual Property Rights. Autoliv
represents and warrants to Alexza that:

          (a) Autoliv is the sole owner of the Autoliv Patents and Autoliv IP and has the right to grant
the licenses set forth in Section 9.8; and

          (b) The patents and patent applications set forth on Exhibit F, together with

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

the Foreign Counterparts of such patents and patent applications, comprise all patents and
patent applications owned or controlled by Autoliv or its Affiliates as of the Effective Date that
are necessary to make Chemical Heat Packages.

     8.4 Disclaimer. THE EXPRESS WARRANTIES IN THIS ARTICLE 8 AND SECTION 11.4 ARE IN LIEU OF ALL
OTHER WARRANTIES, WHETHER EXPRESS, IMPLIED, OR STATUTORY, REGARDING THE CHEMICAL HEAT PACKAGES
INCLUDING ANY WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. EACH PARTY
ACKNOWLEDGES THAT IT HAS RELIED ON NO WARRANTIES OTHER THAN THE EXPRESS WARRANTIES IN THIS ARTICLE
8 AND SECTION 11.4.

ARTICLE 9

Intellectual Property

     9.1 Background Technology. Each party shall retain ownership and control of its respective
inventions, know-how, information, data and related Intellectual Property Rights existing as of the
Effective Date or generated outside this Agreement (collectively, a party’s “Background
Technology”). Except as otherwise set forth in this Agreement, nothing herein shall grant or imply
any license or right of use to any Background Technology of either party to the other party, except
as necessary for the performance of this Agreement.

     9.2 Inventorship. Inventorship of New Discoveries shall be determined in accordance with the
patent laws of the United States of America.

     9.3 Autoliv Inventions. Autoliv shall solely own all Intellectual Property Rights in and to
all New Discoveries made, conceived, reduced to practice or generated by Autoliv alone. (the
“Autoliv IP”).

     9.4 Alexza Inventions. Alexza shall solely own all Intellectual Property Rights in and to all
New Discoveries made, conceived, reduced to practice or generated by Alexza alone (collectively,
“Alexza IP”).

     9.5 Joint Inventions. Alexza and Autoliv shall jointly and equally own all Intellectual
Property Rights in and to all New Discoveries made, conceived, reduced to practice or generated by
the parties jointly (collectively, “Joint IP”), provided that (a) Autoliv may use, and grant
licenses to third parties to, the Joint IP, in all fields other than the Alexza Field without
compensation or accounting to or consent of Alexza, and (b) Alexza may use, and grant licenses to
third parties to, the Joint IP, solely in the Healthcare Field without compensation or accounting
to or consent of Autoliv. The parties shall consult each other and shall mutually decide if it is
appropriate to apply for a patent for the applicable Joint IP, and if so, who will apply for a
patent and in which countries patent protection shall be applied for. Without limiting the
foregoing, (i) Autoliv shall consult with Alexza with respect to each claim in a Joint IP patent
application prosecuted by Autoliv that may relate to the Healthcare Field, and (ii) Alexza shall
consult with Autoliv with respect to each claim in a Joint IP patent application prosecuted by
Alexza that may relate to the Autoliv Field or any portion of the Healthcare Field other than the
Alexza Field. All costs for prosecuting and maintaining patents and patent applications covering

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Joint IP shall be equally shared by the parties unless the parties agree in writing upon an
alternate allocation of such costs. All decisions about the handling of Joint IP shall be
documented. As between the parties, Autoliv will have the first right to initiate legal
proceedings against or take other action against any Third Party that is infringing in the Autoliv
Field any patent that claims Joint IP. As between the parties, Alexza will have the first right to
initiate legal proceedings or take other action against any Third Party that is infringing in the
Healthcare Field any patent that claims Joint IP. If the party with the first right does not
initiate such legal proceedings or otherwise address such infringement within 6 months after the
other party’s written request, then the other party shall have the right to do so. The initiating
party shall be entitled to retain all proceeds from such legal proceedings or other actions
provided that such infringement was limited to the relevant field.

     9.6 Patent Applications. Subject to Section 9.5, each party shall have the right, but not the
obligation, to file, prosecute, maintain, enforce and defend any patents which claim New
Discoveries which such party owns pursuant to this Article 9.

     9.7 Licenses to Autoliv. Subject to the terms and conditions of this Agreement, Alexza hereby
grants to Autoliv: (a) a non-exclusive, royalty-free, non-transferable, non-sublicensable license
under all Background Technology owned by Alexza and all Alexza IP in each case that is necessary or
useful to manufacture or test the Chemical Heat Packages, solely for the purposes of manufacturing
and testing Chemical Heat Packages for Alexza in accordance with the terms and conditions of this
Agreement, and (b) an exclusive, worldwide, royalty-free, fully paid, perpetual, irrevocable, and
sublicensable license to practice all Alexza IP solely in the Autoliv Field.

     9.8 Licenses to Alexza. Subject to the terms of this Agreement, Autoliv hereby grants to
Alexza: (a) a nonexclusive, worldwide, royalty-free, fully paid, perpetual, irrevocable (unless
Autoliv terminates this Agreement pursuant to Section 10.4(a)) and sublicensable license, under all
Autoliv Patents and other Background Technology owned by Autoliv, to develop, make, use, import,
offer for sale and sell Finished Products, (b) a nonexclusive, worldwide, royalty-bearing (as set
forth in Section 10.5(b)), perpetual, irrevocable (unless Autoliv terminates this Agreement
pursuant to Section 10.4(a)) and sublicensable license, under all Autoliv Patents and other
Background Technology owned by Autoliv, to manufacture and have manufactured Chemical Heat Packages
and to develop, make, use, import, offer for sale and sell products incorporating such Chemical
Heat Packages, (c) a nonexclusive, worldwide, royalty-bearing (as set forth in Section 5.6(a)),
perpetual, irrevocable (unless Autoliv terminates this Agreement pursuant to Section 10.4(a)) and
sublicensable license, under all Autoliv Patents and other Background Technology owned by Autoliv,
to manufacture and have manufactured Second Generation Packages and to develop, make, use, import,
offer for sale and sell products incorporating Second Generation Packages, (d) a non-exclusive,
royalty-bearing (as set forth in Section 5.6(a)), perpetual, irrevocable (unless Autoliv terminates
this Agreement pursuant to Section 10.4(a)) and sublicensable license to practice all Autoliv IP
solely in the Alexza Field, and (e) an exclusive, fully paid, perpetual, irrevocable (unless
Autoliv terminates this Agreement pursuant to Section 10.4(a)) and sublicensable license, under
Autoliv’s interest in the Joint IP, to practice the Joint IP solely in the Alexza Field. Alexza
acknowledges that the foregoing licenses are limited to Intellectual Property Rights that are owned
or controlled by Autoliv and do not include licenses to Intellectual Property Rights that are owned
or controlled by Affiliates of

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Autoliv. Alexza may only practice the license set forth in subsection (b) of this Section 9.8
after the termination of this Agreement or in accordance with Section 2.5(a).

ARTICLE 10

Term; Termination

     10.1 Term. The term of this Agreement shall begin on the Effective Date and will continue
until the earlier of (a) the effective date of any termination of this Agreement in accordance with
this Article 10, or (b) December 31, 2012. Thereafter, the term of the Agreement may be extended
by written mutual agreement.

     10.2 Termination for Convenience. Either party may terminate this Agreement upon thirty-six
(36) months prior written notice to the other party for any reason, subject to Article 10.5

     10.3 Termination For Failure to Agree Upon Price. Either party may terminate this Agreement
upon thirty (30) months prior written notice to the other Party if the parties fail to agree upon
the purchase price for Chemical Heat Packages pursuant to 5.1(b).

     10.4 Termination for Cause.

          (a) Either party may terminate this Agreement upon written notice to the other party in the
event of a material breach by the other party, which breach remains uncured for thirty (30) days
after written notice of such breach is provided to the breaching party. In the event of Autoliv’s
termination of this Agreement under this Section 10.4(a), the licenses granted under Section 9.8
shall terminate.

          (b) Autoliv may terminate this Agreement for cause upon written notice to Alexza if Alexza
does not comply with the then-applicable NASDAQ Global Market listing maintenance requirements
within thirty (30) days after Autoliv’s written notice of such non-compliance.

          (c) Alexza may terminate this Agreement upon written notice if Autoliv (i) breaches its
representations and warranties in Section 8.2 by delivering (over the course of one or more
deliveries) ten thousand (10,000) units or more containing one percent (1%) or more of the same or
substantially similar defects, (ii) makes three (3) or more deliveries of Chemical Heat Packages
within any consecutive three (3) month period more than five (5) days after the delivery date
specified in the applicable Release, or (iii) Autoliv closes all of its Northern Utah facilities
and Alexza does not approve of the new location at which Autoliv plans to perform its activities
hereunder. However, Alexza’s right to terminate for defects and/or delivery issues under Section
10.4 (c)(i) or (c)(ii) shall expire 90 days after Alexza knew of or should have known of such
defects or delays.

     10.5 Consequences of Termination.

          (a) Upon expiration of this Agreement pursuant to Section 10.1 or termination of this
Agreement by either party pursuant to Section 10.2, 10.3 or 10.4: (i) Alexza shall reimburse
Autoliv for any unused materials, equipment, tooling or components for which Alexza

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

has not fully reimbursed Autoliv in accordance with Section 3.2, (ii) Autoliv shall transfer
to Alexza possession and ownership of all such materials and components, which shall be in good
condition when transferred, (iii) Autoliv shall transfer to Alexza possession and ownership of all
equipment and tools used by Autoliv in the manufacture and testing of the Chemical Heat Packages,
which shall be in good working order when transferred, and (iv) the parties shall cooperate in good
faith and arrange for an orderly transition of the manufacturing process to Alexza or its designee.

          (b) Upon expiration of this Agreement pursuant to Section 10.1 or termination of this
Agreement by either party pursuant to Section 10.2, 10.3 or 10.4 (unless Autoliv terminates this
Agreement pursuant to Section 10.4(a)), Alexza shall pay Autoliv the following amounts, within
sixty (60) days of the end of each calendar quarter: (i) [ * ] of the direct cost (as defined
below) for Alexza’s manufacture of Chemical Heat Packages, or (ii) [ * ] of the purchase price (not
including any taxes, shipping costs or handling fees) Alexza pays to a Third Party manufacturer for
supplying the Chemical Heat Packages. For the purpose of this Section 10.5(b), “direct costs”
shall mean Alexza’s costs of direct labor, bill of materials, and consumables needed to produce and
approve for use Chemical Heat Packages.

          (c) Except as otherwise set forth in this Agreement, any termination or expiration of this
Agreement shall not relieve either party of any obligation which has accrued prior to the effective
date of such termination or expiration, which obligations shall remain in full force and effect for
the period provided therein.

          (d) At Alexza’s written request at any time after termination of this Agreement (other than a
termination of the Agreement by Autoliv under Section 10.4(a)), Autoliv shall disclose and transfer
to Alexza including, without limitation, through visitation to and observation of the Autoliv
facility where the Pilot Production Line or any other production line for Chemical Heat Packages is
located, all data, know-how, technology and other information reasonably necessary for Alexza to
understand and duplicate the processes employed by Autoliv in the manufacture of the Chemical Heat
Packages in accordance with the Specifications, and provide Alexza with access to Autoliv personnel
as reasonably required to enable Alexza to assume manufacturing activities for the Chemical Heat
Packages, including setting up of a production line for such manufacture. Alexza will, within
forty-five (45) days after receipt of Autoliv’s applicable invoice, pay Autoliv’s reasonable
full-time equivalent costs for each Autoliv personnel who assists Alexza with assuming
manufacturing activities as described in this Section and other reasonable costs incurred for such
assistance. In any event, Autoliv shall not be obligated to provide more than reasonable hours of
assistance, not to exceed two thousand (2,000) hours.

          (e) The remedies set forth in this Section 10.5 are not the sole remedies available to either
party in the event of breach of this Agreement by the other party.

          (f) The terms of Sections 5.3 (solely with respect to conforming Chemical Heat Packages
delivered prior to termination), 5.4, 5.6, 5.8, 7.2 and 10.5, Articles 8, 9, 11, 12 and 13, and
Paragraphs 11, 13, 15 and 16 of the Quality Terms shall survive any termination or expiration of
this Agreement.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

ARTICLE 11

Indemnification; Insurance Coverage

     11.1 Indemnification by Alexza. Alexza hereby agrees to indemnify, hold harmless and defend
Autoliv and its Affiliates and their respective employees, officers, directors and agents (the
“Autoliv Indemnitees”) against any and all expenses, costs of defense (including without limitation
attorneys’ fees, witness fees, damages, judgments, fines and amounts paid in settlement) and any
amounts any Autoliv Indemnitee becomes legally obligated to pay because of any Third Party claim or
claims against it to the extent that such claim or claims (a) arise out of the breach or alleged
breach of any representation or warranty by Alexza hereunder, or (b) arise from a Third Party claim
of injury or death or damage to property resulting from such Third Party’s use of the Finished
Product and not caused by Autoliv’s negligence or misconduct in the performance of its obligations
under this Agreement, or (c) are due to the negligence or misconduct of Alexza in the promotion,
marketing or sale of the Finished Product; provided that such indemnification obligation shall not
apply to the extent such claims are covered by Autoliv’s indemnity set forth in Section 11.2 below.

     11.2 Indemnification by Autoliv. Autoliv shall indemnify, hold harmless and defend Alexza and
its Affiliates and their respective employees, officers, directors and agents (the “Alexza
Indemnitees”) against any and all expenses, costs of defense (including attorneys’ fees, witness
fees, damages, judgments, fines and amounts paid in settlement) and any amounts any Alexza
Indemnitee becomes legally obligated to pay because of: (a) the injury or death of a Third Party
or damage to property of a Third Party judicially determined to have been caused by Autoliv’s
breach of its warranty in Section 8.2(b); or (b) Autoliv’s breach of its warranties in Section 8.3.
Autoliv shall only be liable under this Section 11.2(a) up to a maximum of $1 million for each
individual matter.

     11.3 Procedure. Each party’s agreement to indemnify, defend and hold the other harmless under
Sections 11.1 and 11.2 is conditioned on the indemnified party (a) providing written notice to the
indemnifying party of any claim arising out of the indemnified activities within thirty (30) days
after the indemnified party has knowledge of such claim; (b) permitting the indemnifying party to
assume full responsibility to investigate, prepare for and defend against any such claim; (c)
assisting the indemnifying party, at the indemnifying party’s reasonable expense, in the
investigation of, preparation for and defense of any claim; and (d) not compromising or settling
such claim with the indemnifying party’s written consent. In the event that the parties cannot
agree as to the application of Sections 11.1 and 11.2 above to any particular loss or claim, the
parties may conduct separate defenses of such claim. Each party further reserves the right to
claim indemnity from the other in accordance with Section 11.1 and 11.2 above upon resolution of
the underlying claim, notwithstanding subsection (b) above.

     11.4 Insurance Coverage. Subject to Autoliv’s right to self-insure, each party represents and
warrants that it is covered and will continue to be covered by a comprehensive insurance program
which covers all of each party’s activities and obligations hereunder. Each party shall provide the
other party with written notice at least fifteen (15) days prior to any cancellation or material
change in such insurance program that reduces coverage thereunder. Each party shall maintain such
insurance program, or other program with comparable coverage, beyond the expiration or termination
of this Agreement during (i) the period that any Chemical

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Heat Package produced pursuant to this agreement is intended to be used in a Finished Product
for clinical trials or commercial sales and (ii) a commercially reasonable period thereafter.

ARTICLE 12

Confidentiality

     12.1 Nondisclosure of Confidential Information. The parties agree that during the Term and
for a period of seven (7) years thereafter, each party will (a) use commercially reasonable efforts
to maintain in confidence the Confidential Information of the other party (but not less than those
efforts as such party uses to maintain in confidence its own proprietary industrial information of
similar kind and value) and not to disclose such Confidential Information to any Third Party
without prior written consent of the other party, except for disclosures made in confidence to any
Third Party under terms consistent with this Agreement and made in furtherance of this Agreement or
of rights granted to a party hereunder, and (b) not use such other party’s Confidential Information
for any purpose except those permitted by this Agreement (it being understood that this subsection
(b) shall not create or imply any rights or licenses not expressly granted under Article 9. In any
event, the parties agree to take all reasonable action to avoid disclosure of Confidential
Information except as permitted hereunder.

     12.2 Exceptions. The obligations in Section 12.1 shall not apply with respect to any portion
of the Confidential Information of a party (the “Disclosing Party”) that the other party (the
“Receiving Party”) can show by competent written proof:

          (a) is publicly disclosed by the Disclosing Party, either before or after it is disclosed to
the Receiving Party hereunder; or

          (b) was known to the Receiving Party or any of its Affiliates, without obligation to keep it
confidential, prior to disclosure by the Disclosing Party; or

          (c) is subsequently disclosed to the Receiving Party or any of its Affiliates by a Third Party
lawfully in possession thereof and without obligation to keep it confidential; or

          (d) is published by a Third Party or otherwise becomes publicly available or enters the public
domain, either before or after it is disclosed to the Receiving Party; or

          (e) has been independently developed by employees or contractors of the Receiving Party or any
of its Affiliates without the aid, application or use of Confidential Information.

     12.3 Authorized Disclosure.

          (a) A party may disclose the Confidential Information belonging to the other party to the
extent such disclosure is required by law or regulation or by the order of a court or similar
judicial or administrative body, provided such party gives prompt prior written notice to the other
party and cooperates with the other party to obtain, at the other party’s reasonable expense, a
protective order requiring that the Confidential Information so disclosed be used only for the
purposes for which the law or regulation requires or the order was issued.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

          (b) In addition, Alexza may disclose the Confidential Information of Autoliv (i) to contract
manufacturers (but only prior to termination to the extent allowed by Section 2.5(a) or after
termination to enable such contract manufacturers to assume Chemical Heat Package manufacturing
activities transferred to Alexza pursuant to Section 10.5(d)), bona fide potential and actual
corporate partners, licensees and sublicensees, financial underwriters, and prospective investors,
lenders, acquirers and merger partners, and other parties with a need to know such information, or
(ii) to the extent such information is necessary to file or prosecute patent applications, obtain
regulatory approval for the Finished Products, prosecute or defend litigation, or establish rights
or enforce obligations under this Agreement.

     12.4 Terms of Agreement. The parties agree that the terms of this Agreement and the
Development Agreement will be considered Confidential Information of both parties. Such terms may
be disclosed (a) by either party to its investment bankers, employees, consultants and agents and
its potential or actual investors, lenders, acquirers and merger partners, (however, neither party
shall publicly announce or disclose in any annual report to shareholders or other shareholder
information, unless legally required to do so or upon prior mutual agreement or approval), (b) by
Alexza to its bona fide potential and actual corporate partners, licensees and sublicensees, or (c)
by either party to regulators or other parties for filing or prosecuting patent applications,
prosecuting or defending any litigation, or establishing or enforcing obligations under this
Agreement. Prior to any disclosure, any entity receiving such confidential information must be
bound in writing by similar obligations of confidentiality and non-use at least equivalent in scope
to those set forth in this Article 12. In addition, a copy of this Agreement may be filed by
either party with the Securities and Exchange Commission. In connection with any such filing, such
party shall endeavor to obtain confidential treatment of economic and trade secret information.

     12.5 Termination of Prior Agreements. This Agreement terminates the Mutual CDA. All
Information exchanged between the parties under such earlier agreement shall be deemed Confidential
Information and shall be subject to the terms of this Article 12.

ARTICLE 13

Miscellaneous

     13.1 Assignment. Except as otherwise provided herein, neither this Agreement nor any interest
hereunder will be assignable in part or in whole by any party without the prior written consent of
the other; provided, however, that either party may assign this Agreement to any of its Affiliates
or to any successor by merger or sale of all or substantially all of its business assets to which
this Agreement relates in a manner such that the assignor will remain liable and responsible for
the performance and observance of all its duties and obligations hereunder. This Agreement will be
binding upon the successors and permitted assigns of the parties and the name of a party herein
will be deemed to include the names of such party’s successors and permitted assigns to the extent
necessary to carry out the intent of this Agreement. Any assignment which is not in accordance
with this Section 13.1 will be void.

     13.2 Agency. Neither party is, nor will be deemed to be, an employee, agent or legal
representative of the other party for any purpose. Neither party will be entitled to enter into
any contracts in the name of, or on behalf of the other party, nor will a party be entitled to
pledge the

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

credit of the other party in any way or hold itself out as having authority to do so. This
Agreement is an arm’s-length agreement between the parties and shall not constitute or be construed
as a joint venture.

     13.3 Employees. Autoliv and Alexza shall have a written agreement with each of its employees
and consultants requiring them to comply with obligations with respect to ownership set forth in
Article 9 and confidentiality set forth in Article 12. Either party shall be permitted to solicit
the services of, or offer employment to, any person who is or was an employee of the other party,
upon the other party’s written consent.

     13.4 Amendment. No amendment or modification hereof shall be valid or binding upon the
parties unless made in writing and signed by both parties.

     13.5 Notices. Any notice or other communication required or permitted to be given to either
party hereto shall be in writing unless otherwise specified and shall be deemed to have been
properly given and to be effective on the date of delivery if delivered in person or by facsimile
or overnight courier, or three (3) days after mailing by registered or certified mail, postage
paid, to the other party at the following address:

In the case of Alexza:

Alexza Pharmaceuticals, Inc.

Attention: President and CEO and separate copy to CFO

1020 E. Meadow Circle

Palo Alto, CA 94303

Telephone: (650) 687-3000

Facsimile Number: (650) 687-3999

In the case of Autoliv:

Autoliv North America

Attention: President

3350 Airport Road

Ogden, UT 84405

Telephone: (801) 625-8214

Facsimile Number: (801) 625-8211

Either party may change its address for communications by a notice to the other party in accordance
with this Section.

     13.6 Force Majeure. Any prevention, delay or interruption of performance by any party under
this Agreement shall not be considered a breach of this Agreement if and to the extent caused by
occurrences beyond the reasonable control of the party affected, including but not limited to acts
of God, embargoes, strikes or other concerted acts of workers, fire, flood, earthquake, explosion,
riots, wars, civil disorder, rebellion or sabotage. The party suffering such occurrence shall
immediately notify the other party and any time for performance hereunder shall be extended by the
actual time of prevention, delay, or interruption caused by the

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

occurrence. For the purposes of this Agreement, delays by Autoliv’s subcontractor(s) shall be
deemed to be within Autoliv’s reasonable control, unless caused by one of the foregoing reasons.
The party asserting force majeure shall mitigate its effects.

     13.7 Export Control. This Agreement is made subject to any restrictions concerning the export
of products or technical information from the United States of America or other countries that may
be imposed upon or related to Alexza or Autoliv from time to time. Each party agrees that it will
comply with all applicable export laws and regulations in connection with its activities under this
Agreement.

     13.8 Severability. If any term, condition or provision of this Agreement is held to be
unenforceable for any reason, it shall, if possible, be interpreted, to achieve the intent of the
parties to this Agreement to the extent possible rather than voided. If not capable of such
interpretation, the parties shall in good faith seek to agree on an alternative provision
reflecting the intent of the parties which is enforceable. In any event, all other terms,
conditions and provision of this Agreement shall be deemed valid and enforceable to the full
extent.

     13.9 Governing Law and Venue. The validity, construction and performance of this Agreement
shall be governed by the substantive law of the State of New York, and the United States of
America, without giving effect to conflicts of law principles that would require the application of
the law of a different jurisdiction. Any action or proceeding brought by Alexza to enforce the
terms of this Agreement shall be brought in the County of Salt Lake, State of Utah (if under State
law) or the District Court of Utah (if under Federal Law). Any action or proceeding brought by
Autoliv to enforce the terms of’ this Agreement shall be brought in the County of Santa Clara,
State of California (if under State law) or the District Court for the Northern District of
California (if under Federal Law). The parties consent to personal jurisdiction before such
courts.

     13.10 Construction. The headings of Articles and Sections of this Agreement are for
convenience and are not to be used in interpreting this Agreement. As used in this Agreement, the
word “including” means “including but not limited to.”

     13.11 Cumulative Rights. The rights, powers and remedies hereunder shall be in addition to,
and not in limitation of, all rights, powers and remedies provided at law or in equity, or under
any other agreement between the parties. All of such rights, powers and remedies shall be
cumulative, and may be exercised successively or cumulatively.

     13.12 Waiver. No waiver by either party hereto on any breach or default of any of the
covenants or agreements herein set forth shall be deemed a waiver as to any subsequent or similar
breach or default.

     13.13 Entire Agreement. This Agreement (including any Exhibits hereto) constitutes the entire
agreement between the parties with respect to the subject matter hereof, and no oral or written
statement may be used to interpret or vary the meaning of the terms and conditions hereof. This
Agreement supersedes any prior or contemporaneous agreements and understandings, whether written or
oral, between the parties with respect to the subject matter hereof. In the event of any conflict
or inconsistency between the terms of this Agreement and

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

the Quality Terms, the terms of this Agreement shall prevail. For clarity, the Development
Agreement is terminated as of the Effective Date of this Agreement. Notwithstanding Section 5.7 of
the Development Agreement, the following provisions of the Development Agreement shall survive:
Sections 5.5 (first sentence only), 5.6, 6.1, 6.2, 6.3, 6.4, 6.5 (first sentence only), 6.7 and 6.8
and Articles 7, 9, and 10.

     13.14 Counterparts. This Agreement may be executed in one or more counterpart copies, each of
which shall be deemed an original and all of which taken together shall be deemed to constitute one
and the same instrument. This Agreement shall become binding when one or more counterparts taken
together shall have been executed and delivered by the parties.

     13.15 Further Assurances. Each party shall execute such other instruments, give such further
assurances and perform such acts that are or may become necessary or appropriate to effectuate and
carry out the provisions of this Agreement.

     IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the Effective
Date by their officers thereunto duly authorized.

	 	 	 	 	 
	Alexza Pharmaceuticals, Inc.

	 	Autoliv ASP, Inc.	 	 
	 
	 	 	 	 
	/s/ Thomas B. King
 

Signature

	 	/s/ Michael J. Ward
 

Signature
	 	 
	Thomas B. King
 

Name

	 	Michael J. Ward
 

Name
	 	 
	President & CEO
 

Title

	 	President, Autoliv ASP
 

Title
	 	 
	 
	 	 	 	 
	November
2, 2007
 

Date

	 	November 2, 2007
 

Date
	 	 

List of Exhibits

	A.	 	Chemical Heat Package Drawing No. PNR002119, “Chemical Heat Package”

	 
	B.	 	

Technical Requirements for Chemical Heat Packages, SPS 002002
	 
	C.	 	Purchase Price
	 
	D.	 	Key Personnel; Operations Representative
	 
	E.	 	Quality Terms
	 
	F.	 	Autoliv Patents and Patent Applications

+++++++++++++++++++++++++++++++++++

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Exhibit A

Chemical Heat Package Description

[ * ]

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Exhibit B

Technical requirements for Chemical Heat Packages, SPS 002002

	 	 	 	 	 
	
	 	Released For:
	 	101168 Rev. 01
	 	MASTER FILE	 	 
	 	Technical Requirements for Chemical Heat Package

	1.0	 	PURPOSE
	 
	 	 	• This document lists requirements that the chemical heat package (PNR002119, Heat
Package, Seam Weld, Binder Free) needs to meet when supplied to Alexza Pharmaceuticals.
	 
	2.0	 	SCOPE
	 
	 	 	• This document defines requirements which apply to the CPD chemical heat package. It
is controlled and maintained within Alexza Pharmaceutical’s document control system. All
changes will be made under the Alexza Change Control System.
	 
	3.0	 	RESPONSIBILITIES
	 
	 	 	• It is the responsibility of those organizations noted below to read and understand
this document.
	 
	 	 	• It is the responsibility of the Project Leader to generate and maintain this
document.

	 	 	 
	Product Research and Development

	 	Review and approve the 101168
	Manufacturing

	 	Review and approve the 101168
	Quality Assurance

	 	Review and approve the 101168
	Supply Chain Management

	 	Review and approve the 101168

	4.0	 	REFERENCES
	 
	 	 	• ISTA procedure 3A, Packaged-Products for Parcel Delivery System Shipment 70kg (150
lb) or Less.
	 
	 	 	IEC/EN 60068-2-27, Basic environmental testing procedures — Part 2: Tests; test Ea and
guidance: Shock
	 
	 	 	IEC/EN 60068-2-64, Environmental testing — Part 2: Test methods — Test Fh: Vibration,
broad-band random (digital control) and guidance

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

	 	 	IEC/EN 60068-2-6, Environmental testing — Part 2: Tests; test Fc: Vibration (sinusoidal)
	 

	 	•	 	ALXSPSD-0010, Thermal Testing of Heat Packages
	 
	 	•	 	ALXSPSD-0023, Leak Check and Electrical Check
	 

	5.0	 	DEFINITIONS AND ACRONYMS

	 	 	 
	Cpk

	 	Type of process capability index. Normally expressed
as the minimum of [(upper specifications limit –
mean)/3s , (mean – lower specification
limit)/3s ]
	 
	 	 
	Header

	 	Component of heat package.
	 
	 	 
	Heat shield

	 	Component of heat package.
	 
	 	 
	HP

	 	Heat Package
	 
	 	 
	IEC

	 	International Electrochemical Commission
	 
	 	 
	ISO

	 	International Organization for Standardization
	 
	 	 
	ISTA

	 	International Safe Transit Association
	 
	 	 
	Lid

	 	Component of heat package
	 
	 	 
	μ

	 	Micron
	 
	 	 
	μm

	 	Micrometer
	 
	 	 
	ms

	 	Milliseconds
	 
	 	 
	Multiple initiations

	 	The reaction of reactant coated on the inside of the
heat package starts at multiple locations.
	 
	 	 
	NMT

	 	Not more than
	 
	 	 
	Normal heat package

	 	Heat package meets all the performance requirements
as specified in section 7.0 of this document.
	 
	 	 
	Propagation time

	 	Time from actuation (reactant on surface is actuated)
until the heating reaction is complete (all reactant
has reacted).
	 
	 	 
	RSD

	 	Relative Standard Deviation
	 
	 	 
	s

	 	Standard deviation
	 
	 	 
	T250

	 	Average surface temperature measured 250 ms after
actuation.
	 
	 	 
	TBD

	 	To be determined
	 
	 	 
	Tray

	 	Component of heat package

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

	6.0	 	OVERALL DESCRIPTION

	 	6.1	 	The Chemical Heat Package (PNR002119)
	 
	 	 	 	• The heat package assembly consists of a lid and tray coated on one side with
reactant, a header with a welded bridge wire and starter material, and a heat
shield. The heat package is seam welded along the edges of the lid and tray flanges
and the header is sealed with UV curable adhesive.

Figure 1 — Exploded View of a Heat Package

	7.0	 	PERFORMANCE REQUIREMENTS
	 
	 	 	During lot acceptance testing, heat packages should be verified to meet requirements 1, 2,
3, 4, 6, 7 and 12. Requirements 1, 2, 3, 4 and 6 are destructive tests and should therefore
be verified for a representative sample of heat packages from a particular lot.

	 	 	 	 	 
	 	 	Testing	 	 
	Attribute	 	Method	 	Requirement
	1. Temperature

	 	ALXSPSD-0010
	 	[ * ]
	2. Temperature uniformity

	 	ALXSPSD-0010
	 	[ * ]
	3. Multiple initiations

	 	ALXSPSD-0010
	 	[ * ]
	4. Propagation time

	 	ALXSPSD-0010
	 	[ * ]
	5. Pressure inside HP

	 	ALXSPSD-0010
	 	[ * ]
	6. Heat package weld and metal integrity

	 	ALXSPSD-0011
	 	[ * ]

 
 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

	 	 	 	 	 
	 	 	Testing	 	 
	Attribute	 	Method	 	Requirement
	7. He leak rate before actuation

	 	ALXSPSD-0023
	 	[ * ]
	8. He leak rate after actuation – use
environment, temperature

	 	ALXSPSD-0023
	 	[ * ]
	9. He leak rate after actuation,
– use environment, altitude

	 	ALXSPSD-0023
	 	[ * ]
	10. Actuation reliability, — use
environment temperature

	 	ALXSPSD-0010
	 	[ * ]
	11. Actuation reliability, — use
environment altitude

	 	ALXSPSD-0010
	 	[ * ]
	12. Header resistance before actuation

	 	ALXSPSD-0023
	 	[ * ]
	13. Header resistance after actuation

	 	ALXSPSD-0023
	 	[ * ]
	14. Shelf life

	 	N/A
	 	[ * ]
	15. Shelf life

	 	N/A
	 	[ * ]
	16. Shipping requirement

	 	N/A
	 	[ * ]
	17. Mechanical Shock

	 	N/A
	 	[ * ]
	18. Sinusoidal Vibration

	 	N/A
	 	[ * ]
	19. Random Vibration (broad band)

	 	N/A
	 	[ * ]
	20. Orientation

	 	TBD
	 	[ * ]

+++++++++++++++++++++++++++++++

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Exhibit C

Purchase Price

During the Initial Term, the purchase price for the Chemical Heat Packages will be as set forth
below corresponding to the annual (calendar year) quantities set forth below:

	 	 	 
	Annual Quantity	 	Purchase Price
	(in units)	 	(in USD)
	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]

++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Exhibit D

Key Personnel; Operations Representative

	A.	 	Key Personnel:

	 	 	 	 	 
	Name	 	Position	 	Role
	[ * ]
	 	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]
	 	[ * ]

	B.	 	Operations Representative:
	 
	 	 	[ * ]

+++++++++++++++++++++++++++++++++++++++++

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Exhibit E

Quality Terms

	1.	 	PURPOSE
	 
	 	 	This exhibit defines the quality responsibilities between Alexza and Autoliv with
respect to the quality assurance of the CPD Heat Packages manufactured by Autoliv for
Alexza
	 
	2.	 	SCOPE
	 
	 	 	This exhibit is applicable to the CPD Heat Packages manufactured by Autoliv.
	 
	3.	 	QUALITY SYSTEM
	 
	 	 	Autoliv shall establish, document and maintain a quality system in accordance with
ISO/TS 16949 Quality Management System Standard. Autoliv shall notify Alexza in advance
in the event that Autoliv is required to change their Quality Management Standard
(ISO/TS 16949).
	 
	 	 	The Autoliv quality system shall consist of written procedures for the control of
planned and unplanned changes to materials, packaging components, suppliers, equipment,
processing steps, device component requirements, sampling test methods and releasing
requirements.
	 
	4.	 	QUALITY AND BUSINESS REVIEW
	 
	 	 	Alexza and Autoliv shall conduct Quality and Business Reviews according to the
manufacturing and supply agreement. The appropriate Alexza & Autoliv Quality Engineer
and/or Supply Team Lead or other appropriate personnel shall lead such event(s).
	 
	5.	 	COMPLIANCE
	 
	 	 	Autoliv shall manufacture Alexza products in compliance with Autoliv’s established
quality system procedures, ISO/TS 16949 standard and applicable regulations. Autoliv
shall be responsible for maintaining certification to the current ISO/TS 16949 standard.
	 
	6.	 	AUDITS
	 
	 	 	Alexza shall have the right, upon reasonable notice to Autoliv and during regular
business hours to audit, observe (person in plant), or inspect the facilities being used
by Autoliv for production and storage of the CPD Heat Package. Alexza shall audit for
compliance to the approved Autoliv procedures relating to manufacturing of CPD Heat
Packages and to the ISO/TS 16949 standard. Autoliv shall within thirty (30) calendar
days of receipt of the written audit letter, remedy or cause the remedy of any
deficiencies

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

	 	 	which may be noted. If deficiencies cannot reasonably be remedied within such thirty
(30) business-day period, a written plan to remedy such deficiencies will be presented
to Alexza.
	 
	7.	 	REGULATORY INSPECTIONS
	 
	 	 	Autoliv shall notify Alexza within twenty four (24) hours of any inspection notification
from any regulatory agency specifically related to the manufacture and storage of CPD
Heat Packages. Autoliv shall provide Alexza copies of any inspection reports that it
receives from any regulatory agency or any notice of any claim or action by any agency
relating to non-compliance with any applicable laws, rules or regulations. Autoliv shall
contact Alexza for instructions with regards to validity of a request about Alexza
products by a regulatory agency. Except to the extent as may be required by law, Autoliv
shall not communicate directly with any regulatory agency (such as FDA or sanctioning
authority) regarding the CPD Heat Package except through or with the explicit review and
approval of Alexza.
	 
	8.	 	DESIGN SPECIFICATIONS
	 
	 	 	Specifications and drawings for CPD Heat Package components, packaging components, and
the completed CPD Heat Package will be created and approved by Alexza according to
Alexza’s change control process. Approved specifications and drawings will be
transferred to Autoliv by Alexza.
	 
	9.	 	MANUFACTURING INSTRUCTIONS
	 
	 	 	Alexza and Autoliv are jointly responsible for ensuring the appropriate process controls
are implemented. Autoliv is responsible for creation and approval of the manufacturing
control plan(s) according to Autoliv’s change control process. Alexza will approve the
Autoliv manufacturing control plan(s) as well as references within the CPD Heat Package
control plan(s)
	 
	10.	 	CHANGE CONTROL
	 
	 	 	Autoliv shall not make changes to the design, materials, packaging components,
requirements or process changes affecting safety, specifications, or stability
requirements of the Alexza CPD Heat Package without prior written approval from Alexza.
Autoliv is responsible for notifying and obtaining Alexza’s approval for any changes to
the manufacturing control plan(s) prior to implementation and for providing Alexza with
a copy of the most current approved control plan(s).
	 
	11.	 	IDENTIFICATION & TRACEABILITY
	 
	 	 	Autoliv shall maintain a system to assure proper identification and acceptance status of
materials, components and products throughout the manufacturing cycle. The
manufacturing records shall allow for traceability to process, equipment, personnel, and

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

	 	 	materials and components used in the manufacturer of each lot or batch of CPD Heat
Packages. The extent of traceability to the materials and components shall be defined
in the manufacturing control plan(s).
	 
	12.	 	NON-CONFORMANCES
	 
	 	 	Autoliv will notify Alexza of all non-conformances, as determined by the control plan,
associated with manufacturing or testing CPD Heat Packages that are being reviewed for
shipment of the lot to Alexza or that affect product that has already been shipped to
Alexza.
	 
	13.	 	LOT RELEASE AND CERTIFICATE OF ANALYSIS
	 
	 	 	Autoliv is responsible for reviewing completed manufacturing and testing records to
ensure each lot of CPD Heat Packages has been manufactured and tested in accordance to
the approved manufacturing instructions and that any deviations to the process have been
thoroughly investigated. Autoliv is responsible for disposition of each lot of CPD Heat
Packages prior to shipment to Alexza. Autoliv will generate a Certificate of
Conformance (C of C) for each lot and the C of C will be provided to Alexza. The C of C
will contain traceability to the lot and a compliance statement indicating the lot has
been manufactured and tested according to the approved control plan(s) and meets all
requirements of the product specification. Upon request, Alexza may request copies of
the completed manufacturing records, test data, or other related records associated with
the lot.
	 
	14.	 	ACCEPTANCE
	 
	 	 	Alexza reserves the right to reject any product that is found not to be in conformance
with the approved product specifications or found not to have been manufactured
according to the approved control plan(s).
	 
	15.	 	RECORDS RETENTION
	 
	 	 	All documentation (manufacturing records, packaging records, inspection records, batch
tickets/card/records, and quality records, such as calibration logs, training records)
generated during the manufacturing process will be maintained by Autoliv for a minimum
of seven (7) years. Autoliv shall notify Alexza prior to destruction of any records
related to the manufacture of device component and relevant quality system records and
transfer such records to Alexza upon request.
	 
	16.	 	FAILURE ANALYSIS
	 
	 	 	When requested by Alexza, Autoliv will perform a complete investigation on returned heat
package(s) in a timely manner sufficient to determine the root cause of the abnormal
condition. An investigation report will be written and submitted to Alexza for review
and approval as soon as reasonably possible.

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

+++++++++++++++++++++++++++++++++++++++++

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

 

 

Exhibit F

AUTOLIV PATENTS AND PATENT APPLICATIONS

	 	 	 	 	 
	Patent Description:
	 	Patent Number:
	 	Also Published as:
	[ * ]
	 	[ * ]
	 	[ * ]
	[ * ]
	 	[ * ]	 	 
	 	 	 	 	 
	Pending Autoliv Review:
	 	Internal File Number:	 	 
	[ * ]
	 	[ * ]	 	 
	 	 	 	 	 
	Autoliv Trade Secret:
	 	File Number:	 	 
	[ * ]
	 	[ * ]	 	 

 

			
	[ * ] =	 	 Certain confidential information contained in this document, marked by brackets, has
been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule
24b-2 of the Securities Exchange Act of 1934, as amended.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]